![hacettepe](https://doktorinfo.hacettepe.edu.tr/images/doktorlar/483/doktorid_483.jpg)
Ad Soyad:
İbrahim H. Güllü
Ünvanı:
Prof.Dr.
Bölüm:
Medikal Onkoloji
İletişim:
İstanbul Atatürk Erkek Lisesi’nden birincilikle mezun oldu. 1984’te Hacettepe Üniversitesi Tıp Fakültesi’ni derece ile bitirdi. Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı’nda uzmanlık eğitimini 1990’da tamamladı. Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı Tıbbi Onkoloji Ünitesi’nde yandal uzmanlık eğitimini 1992’de bitirdi. 1993’te doçent, 1998’de profesör oldu. 1995’te M. D. Anderson Kanser Merkezi’nde klinik araştırmaların yönlendirilmesi konusunda çalıştı. European Society of Medical Oncology (ESMO) ve American Society of Medical Oncology (ASCO) başta olmak üzere birçok bilimsel kuruluş ve derneğin üyesidir. International Journal of Hematology Oncology Dergisi'nin 15 yıldır editörlüğünü yapmakta olup birçok derginin de yayın kurulu üyesidir. 1990’da iç hastalıkları uzmanlığı esnasında Şeref Zileli– En Başarılı Asistan Ödülü’nü, 1996’da Hacettepe Üniversitesi En İyi Klinik Çalışma Yayın Ödülü’nü, 1997’de Medikal Onkolojide Avrupa Sertifikası’nı ve 2001’de Türk Kanser Savaş Kurumu En İyi Araştırma Ödülü’nü, son olarak da Avrupa Gazeteciler Birliği (European Journalist Union) "Yılın Başarılı Bilim Adamı" ödülünü aldı (2009). Kanser tedavisinde yenilikler, metastaz biyolojisi, anjiyogenez ve solid tümör tedavileri ile ilgilenmektedir.
v:* {behavior:url(#default#VML);} o:* {behavior:url(#default#VML);} w:* {behavior:url(#default#VML);} .shape {behavior:url(#default#VML);}
/* Style Definitions */ table.MsoNormalTable { font-size:10.0pt; font-family:"Times New Roman","serif";}
MAKALELER
[A] . YURTİÇİ MAKALELER
[B] . YURTDIŞI MAKALELER
1. [A] Güllü İ. Immunobiology of fetal maternal relationship. Katkı 1983; 4: 942-8.
2. [A] Bakır T, Üzüm K, Karacadağ Ş, Güllü İ. Kist hidatikli hastalarda serum spesifik immünglobulin E’nin tanısal değeri. Karadeniz Tıp Derg 1987; 1: 33-6.
3. [A] Güllü İ, Sivri B, Akalın S. Ketoconazole: Yeni bir steroid sentez inhibitörü. Hacettepe Tıp Derg 1988; 21: 245-51.
4. [A] Özmen F, Güllü İ, Uzun Ö, Karamehmetoğlu A, Oram E. Anstabil angina pektoriste prognoz. Türkiye Klinikleri Kardiyoloji 1989; 2: 238-43.
5. [A] Güllü İ. Non-A, Non-B hepatiti. İç Hastalıkları Bülteni 1989; 4: 3-6.
6. [A] Güllü İ, Tekuzman G, Kars A, Alakavuklar M, Baltalı E, Özışık Y, Fırat D. Baş- boyun tümörlerinde cisplatin, bleomycin, methotrexate, 5 fluorouracil kombine kemoterapisi. Hacettepe Tıp Derg 1989; 22: 369-77.
7. [A] Arıkan S, Güllü İ, Tekuzman G, Akova M. Antifungal tedavide flukonazol. Türk Hematol Onkol Derg 1991; 1: 162-9.
8. [A] Özyılkan Ö, Tekuzman G, Ünlü E, Güllü İ, Güler N, Barışta İ, Baltalı E, Özışık Y, Ruacan Ş, Fırat D. Küçük hücreli akciğer kanserinde performans statüsü ve yaşın prognoza etkisi. Türk Hematol Onkol Derg 1991; 1: 179-82.
9. [A] Demirkazık A, Güllü İ, Baltalı E, Kars A, Tekuzman G, Koç Y, Güler N, Barışta İ, Fırat D. Evre II-IIIA meme kanserlerinde adjuvant kemoterapi olarak L-PAM kullanımı. Türk Hematol Onkol Derg 1991; 1: 133-6.
10.[A] Güllü İ, Tekuzman G, Baltalı E. Induction chemotherapy in head and neck tumors. Turk J Hematol Oncol 1991; 1: 143-9.
11.[A] Özyılkan Ö, Ünlü E, Tekuzman G, Ruacan Ş, Baltalı E, Güler N, Güllü İ, Barışta İ, Özışık Y, Fırat D. Superior vena cava syndrome: A 15 year period experience. Turk J Cancer 1991; 21: 109-15.
12.[A] Özyılkan Ö, Tekuzman G, Ünlü E, Güllü İ, Fırat D. Küçük hücreli akciğer kanseri. Türk Hematol Onkol Derg 1991; 1: 110-3.
13.[A] Barışta İ, Tekuzman G, Baltalı E, Güllü İ, Fırat D, Kansu E, Kars A, Özışık Y, Güler N, Özdemir O. İleri evre Hodgkin lenfomalı hastalarda COPP/ABVD ve ABVD kemoterapileri. Türk Hematol Onkol Derg 1991; 1: 41-8.
14.[A] Güler N, Güllü İ. Antineoplastik ilaçların kardiak ve pulmoner yan etkileri. Türk Hematol Onkol Derg 1991; 1: 49-57.
15.[B] Özdemir O, Güllü İ, Dündar S. Imerslund-Grasbeck syndrome diagnosed in adulthood. Eur J Intern Med 1991; 2: 177-8.
16.[A] Güllü İ, Tekuzman G, Güler N, Barışta İ, Alakavuklar M, Kars A, Özışık Y, Baltalı E, Özdemir O, Kansu E, Fırat D. Baş-boyun tümörlerinde cisplatin, bleomycin, 5- fluorouracil, methotrexate kombine kemoterapisinin değerlendirilmesi. Türk Hematol Onkol Derg 1991; 1: 15-23.
17.[B] Akpolat T, Koç Y, Yeniay İ, Akpek G, Güllü İ, Kansu E, Kiraz S, Batman F, Ersoy F, Kansu T, Akkaya S, Telatar H, Zileli T. Familial Behçet's Disease. Eur J Med 1992; 1: 391-5.
With the Editorial:
Wechsler B, Lé Thi Huong DU, Piette JC. Behçet’s disease (editorial). Eur J Med 1992;1:387-90.
18.[A] Aydoğanlı L, Güllü İ, Yıldız M, Atan A, Akalın Z. Testiste malign lenfoma: Vaka takdimi. Türk Hematol Onkol Derg 1992; 2: 188-9.
19.[A] Güler N, Baltalı E, Koray Z, Kars A, Tekuzman G, Güllü İ, Fırat D. CEA and CA 15-3 in the clinical follow-up of breast carcinoma. Turk J Cancer 1992; 22: 133-42
20.[A] Aka H, Güllü İ, Baltalı E. Colorectal cancers. Turk J Hematol Oncol 1992; 2: 176-82
21.[A] Barışta İ,Tekuzman G, Güllü İ, Özyılkan Ö, Özışık Y, Güler N, Kars A, Baltalı E, Fırat D. Primary colon lymphomas. Kolon Rektum Hast Derg 1992; 2: 173-6.
22.[A] Güler N, Tekuzman G, Kars A, Baltalı E, Güllü İ, Barışta İ, Özyılkan Ö, Fırat D. Opere edilemeyen küçük hücreli olmayan akciğer kanserinde mitomisin, ifosfamid, cisplatin kombine kemoterapisi: Ön rapor. Türk Hematol Onkol Derg 1992;2:150-4.
23.[B] Koç Y, Akpek G, Akpolat T, Güllü İ, Kansu E, Kiraz S, Batman F, Duru S, Kansu T, Akkaya S, Telatar H, Zileli T. Topical sucralfate therapy for oral ulcers in Behçet's disease: A randomized double-blind study. J Dermatol Treat 1992; 3:197-9
24.[A] Güllü İ, Tekuzman G, Barışta İ, Baltalı E, Kars A, Güler N, Özyılkan Ö, Atahan L, Hoşal N, Fırat D. Adjuvant chemotherapy for locally advanced head and neck cancers: Preliminary report. Turk J Hematol Oncol 1992; 2:137-41.
25.[A] Barışta İ, Baltalı E, Güllü İ, Akpolat T, Tekuzman G, Karaağaoğlu E, Sungur A, Kars A, Güler N, Özyılkan Ö, Fırat D. Metastatik meme karsinomlarında metastazların dokulara dağılımını etkileyen faktörler. Türk Hematol Onkol Derg 1992;2:80-5.
26.[B] Koç Y, Güllü İ, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkancı F, Akkaya S, Telatar H, Zileli T. Vascular involvement in Behçet's Disease. J Rheumatol 1992;19:402-10.
With the Editorial by JT Lie:
Lie JT. Vascular involvement in Behçet’s disease: arterial and venous and vessels of all sizes (editorial). J Rheumatol 1992; 19: 341-2.
27.[A] Barışta İ, Güllü İ. Non-Hodgkin lenfomalarda kromozomal değişiklikler. Türk Hematol Onkol Derg 1992;2: 33-5.
28.[A] Akpolat T, Arık N, Özdemir O, Demirkan F, Arınsoy T, Güllü İ, Sungur C, Dündar S, Turgan Ç, Yasavul Ü, Özcebe O, Çağlar Ş, Kirazlı Ş. Effect of DDAVP on hemostatic factors in uremia. Turk J Hematol Oncol 1992;2:147-9.
29.[A] Aka H, Güllü İ, Özdemir O. Fibrinolitik tedavi. Türk Hematol Onkol Derg 1992; 2: 42-8.
30.[A] Güllü İH, Tekuzman G, Baltalı E, Kars A, Barışta İ, Güler N, Özyılkan Ö, Özışık Y, Fırat D. Cisplatin and five-day continous infusion of 5-Fluorouracil in patients with recurrent and disseminated carcinoma of the head and neck cancer. Turk J Cancer 1993; 23:68-74.
31.[A] Güllü İH, Barışta İ, Güler N, Tekuzman G, Sungur A. B-Cell lymphoma with uterine corpus involvement. A case report. J Ankara Med School 1993;15: 617-21.
32.[A] Barışta İ, Tekuzman G, Güllü İH, Özyılkan Ö, Özışık Y, Güler N, Kars A, Baltalı E, Kansu E, Fırat D. Primary non-Hodgkin's lymphoma of the stomach: Diagnostic findings and treatment results. Turk J Cancer 1993;23:118-25.
33.[A] Budak T, Güllü İH, Tekuzman G, Ruacan Ş, Koç Y, Baltalı E, Fırat D. Leukemia and breast involvement. Turk J Cancer 1993; 23: 153-8.
34.[B] Güler N, Tekuzman G, Kars A, Baltalı E, Güllü İH, Barışta İ, Özyılkan Ö, Fırat D. MIC combination chemotherapy regimen in the treatment of inoperable non-small cell lung cancer. In: Recent Advances in Chemotherapy. Proceedings of the XVIII. International Congress of Chemotherapy. Stockholm, Sweden, 1993: 833-4.
35.[B] Güllü İH, Tekuzman G, Barışta İ, Kars A, Güler N, Akpek G, Baltalı E, Kansu E, Fırat D. FAM combination chemotherapy for advanced gastric carcinoma. In: Recent Advances in Chemotherapy. Proceedings of the XVIII. International Congress of Chemotherapy. Stockholm, Sweden, 1993: 839-41.
36.[B] Baltalı E, Güler N, Kiraz S, Barışta İ, Güllü İH, Kars A, Tekuzman G, Fırat D. Comparison of salvage chemotherapy protocols in patients with stage IV breast carcinoma. In: Recent Advances in Chemotherapy. Proceedings of the XVIII. International Congress of Chemotherapy. Stockholm, Sweden, 1993: 968-9.
37.[A] Güllü İH, Barışta İ, Tekuzman G. Cancer and thrombosis. Turk J Cancer 1994; 24: 5-13.
38.[A] Barışta İ, Güllü İH, Akpek G, Eldem B, Demirkazık F, Ayhan A, Baltalı E, Tekuzman G, Fırat D. Non-Hodgkin lenfomalarda oküler ve orbital tutulum. Türk Hematol Onkol Derg 1994;4:54-9.
39.[A] Hastürk S, Alper S, Güllü İH, Kurt B, Özbudak O, Oruç D. Opere over karsinomlu hastada vena cava süperior sendromu. Türk Hematol Onkol Derg 1994;4:45-9.
40.[A] Altınbaş M, Barışta İ, Tekuzman G, Baltalı E, Alkış N, Güllü İH, Güler N, Gököz A, Kölemen F. Mycosis fungoidesli hastalarda tedavi sonuçları. Türkiye Klinikleri Dermatoloji Derg 1994;4:1-4.
41.[B] Turgut M, Baltalı E, Barışta İ, Güllü İH, Güler N, Kars SA, Tekuzman G, Özyılkan Ö, Akpek G, Fırat D. CEF (cyclophosphamide, epirubicin, fluorouracil) and CNF (cyclophosphamide, mitoxantrone, fluorouracil) chemotherapy Protocols in Stage IV Breast Carcinoma. In: Proceedings of the XVI.International Cancer Congress, Rao RS, Deo MG, Sanghvi LD, Mittra I, (eds), New Delhi-India, Oct 30th- Nov 5th 1994, Volume 2, pp:1437-40.
42.[B] Haznedaroğlu Ş, Güllü İH, Haznedaroğlu İ, Baltalı E, Barışta İ, Tekuzman G, Güler N, Altınbaş M, Kars A, Fırat D. The significance of CEA and CA19-9 in the diagnosis and follow up of the gastrointestinal malignancies. In: Proceedings of the XVI. International Cancer Congress, Rao RS, Deo MG, Sanghvi LD, Mittra I (Eds), New Delhi-India, Oct 30th-Nov 5th 1994, Volume 2, pp:1697-8.
43.[A] Özyılkan Ö, Baltalı E, Ahmet E, Tekuzman G, Barışta İ, Güler N, Güllü İ, Fırat D. Ceruloplasmin:Prealbumin ratio in breast cancer. Turk J Hematol Oncol 1994; 5: 74-6.
44.[A] Güllü İH, Tekuzman G, Baltalı E, Barışta İ, Kars A, Güler N, Akpek G, Fırat D. 5- Fluorouracil, adriamycin and mitomycin-C combination chemotherapy for advanced gastric carcinoma. Turk J Cancer 1994;24:147-56.
45.[A] Yalçın Ş, Savaş MC, Güllü İH, Tekuzman G, Barışta İ, Çelik İ, Altınbaş M, Güler N, Kars A, Baltalı E, Fırat D. Efficacy of oral ketorolac tromethamine compared with dypiron in patients with cancer pain. Turk J Hematol Oncol 1994; 4: 146-50.
46.[A] Barışta İ, Güllü İH, Baltalı E, Gököz A, Tekuzman G. Mikozis fungoides tedavisinde interferon ve methotrexate. Dermatopatoloji Derg 1994;3:120-3.
47.[A] Haznedaroğlu Ş, Güllü İH, Haznedaroğlu İ, Baltalı E, Barışta İ, Tekuzman G, Güler N, Altınbaş M, Kars A, Fırat D. Gastrointestinal sistem kanserlerinde CEA ve CA 19-9 tümör belirleyicilerinin klinik ve tedavideki önemi. Acta Oncol Turcica 1994; 27: 53-9.
48.[A] Yalçın Ş, Tekuzman G, Barışta İ, Güllü İH, Abbasoğlu O, Sayek İ, Fırat D. Non- Hodgkin lenfomalı bir olguda gelişen sekonder kolon kanseri. Acta Oncol Turcica 1994;27:95-6.
49.[A] Güllü İ, Benekli M. Langerhans’s cell histiocytosis (Histiocytosis-X). A clonal proliferative disease. Turk J Med Sci 1994; 22: 71.
50.[A] Haznedaroğlu Ş, Güllü İH. Gastrointestinal sistem kanserlerinde tümör belirleyicileri. Türk Hematol Onkol Derg 1995; 5: 158-65.
51.[B] Benekli M, Savaş MC, Güllü İH, Kadayıfcı A, Akpek G, Kars A, Güler N, Kansu E, Tekuzman G, Fırat D. Tumor lysis syndrome following single-dose mitoxantrone. Chemotherapy 1995; 41: 470-2.
52.[B] Barışta İ, Tekuzman G, Güllü İH, Baltalı E, Kars A, Özışık Y, Güler N, Çelik İ, Atahan İL, Fırat D. Non-Hodgkin's lymphomas of the tonsil: A retrospective analysis of twenty-eight patients with primary tonsillary lymphoma. Tumori 1995; 81: 234-7.
53.[B] Atan A, Yıldız M, Aydoğanlı L, Güllü İ, Akalın Z. Phaeochromocytoma in pregnancy: A case report. Int Urol Nephrol 1996; 28: 11-3.
54.[B] Güllü İH, Yalçın Ş, Tekuzman G, Barışta İ, Alkış N, Çelik İ, Zengin N, Güler N, Kars A, Baltalı E, Kansu E, Fırat D. High-dose ifosfamide by infusion with mesna in advanced refractory sarcomas. Cancer Invest 1996; 14: 239-42.
With the Editorial by Patel and Benjamin:
Patel SR, Benjamin RS. Ifosfamide in sarcomas. Is it a schedule dependent drug (editorial). Cancer Invest 1996; 14: 290-1.
55.[B] Akova M, Özcebe O, Güllü İ, Gür D, Akalın E. Sulbactam-ampicillin treatment in diabetic foot. J Chemotherapy 1996; 8: 284-88.
56.[B] Güllü İH, Benekli M, Müderrisoğlu H, Oto A, Kansu E, Kabakcı G, Oram E, Bekdik C. Silent myocardial ischemia in Behçet’s disease. J Rheumatol 1996; 23: 323-7.
With the Editorial by O’Duffy and Hammill:
O’Duffy JD, Hammill SC. Silent myocardial ischemia in Behçet’s disease (editorial). J Rheumatol 1996; 23: 211.
57.[B] Barışta İ, Çelik İ, Güllü İ, Hayran M, Akova M. Integrating the time factor into the definition of metastasis of unknown origin. J Natl Cancer Inst 1996; 88: 51.
58.[B] Benekli M, Güllü İH, Savaş MC, Kadayıfçı A, Altundağ MK, Tekuzman G, Fırat D: Acute tumor lysis syndrome following intrathecal methotrexate. Leukemia Lymphoma 1996; 22: 361-3.
59.[B] Kiraz S, Baltalı E, Güler N, Barışta İ, Benekli M, Çelik İ, Güllü İH, Kars A, Tekuzman G, Fırat D. Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer. J Chemotherapy 1996; 8: 310-4.
60.[A] Kadayıfçı A, Benekli M, Savaş MC, Aslan S, Tekuzman G, Güllü İH: Multiple lenfomatöz polipozis: İki yeni vaka takdimi ve literatürün gözden geçirilmesi. Kolon Rektum Hast Derg 1996; 6: 98-102.
61.[B] Güllü İ, Çelik İ, Tekuzman G, Altunbaş M, Güler N, Barışta İ, Alkış N, Yalçın Ş, Kars A, Baltalı E, Kansu E, Fırat D. Procarbazine, CCNU, vincristine combination in the treatment of brain tumors. Tumori 1996; 82: 228-31.
62.[B] Barışta İ, Baltalı E, Güllü İH, Güler N, Çelik İ, Saraçbaşı O, Tekuzman G, Kars A, Özışık Y, Ruacan Ş, Atahan L, Fırat D. Factors influencing the distribution of metastases and survival in metastatic breast carcinoma. Am J Clin Oncol 1996; 19: 569-73.
63.[A] Benekli M, Güllü İH, Altundağ MK. Kanser ve tromboz. Acta Oncol Turcica 1996; 29: 73-8.
64.[B] Yalçın Ş, Barışta İ, Tekuzman G, Güllü İ, Fırat D. Dramatic response to ifosfamide, mesna and doxorubicin chemotherapy regimen in an adult with clear cell sarcoma of the kidney. J Urol 1996; 155: 2024.
65.[B] Çelik İ, Başçıl N, Güllü İ, Barışta İ, Çamurdanoğlu M. Difficult diagnosis in a patient with multiple osteoblastic thoracal vertebral lesions. Ann Saudi Med 1996; 16: 590.
66.[B] Yalçın Ş, Güler N, Kansu E, Ertenli İ, Güllü İ, Barışta İ, Çelik İ, Kars A, Tekuzman G, Baltalı E, Fırat D. Granulocyte-colony stimulating factor (G-CSF) administration for chemotherapy induced neutropenia. Hematology 1996; 1: 155-61.
67.[B] Haznedaroğlu İC, Güllü İH. Haematologic side effects of ACE inhibitors and a hypothetical local renin-angiotensin system in the bone marrow. Nephron 1997; 77: 111.
68.[B] Çelik İ, Başçıl N, Yalçın Ş, Güllü İH, Kars A, Barışta İ, Tekuzman G. Ifosfamide- based chemotherapy for recurrent or metastatic hemangiopericytoma. Acta Oncol 1997; 36: 348.
69.[B] Çelik İ, Apraş Ş, Kars A, Barışta İ, Güllü İH, Güler N, Kansu E. Persistent hypercalcemia leading to acute pancreatitis in a patient with relapsed myeloma and renal failure. Nephron 1998; 79: 109-10.
70.[B] Kadayıfçı A, Savaş MC, Arslan S, Güllü İH. Ursodeoxycholic acid in the management of prolonged cholestasis due to hepatitis B. J Clin Gastroenterol 1997; 24: 125-6.
71.[B] Haznedaroğlu İC, Savaş MC, Benekli M, Güllü İH, Dündar SV: The significance of megakaryocytopoietic cytokines and thrombopoietin in immune thrombocytopenic purpura: A hypothesis. NZ Med J 1996; 109: 389.
72.[B] Savaş MC, Güllü İH. Nurses annoyed by pinching and nudging. Lancet 1996; 348: 626.
73.[B] Kiraz S, Baltalı E, Güler N, Barışta İ, Benekli M, Çelik İ, Güllü İH, Kars A, Tekuzman G, Fırat D: Ifosfamide and etoposide in previously treated patients with advanced breast cancer. Tumori 1997; 83: 604-7.
74.[A] Yalçın Ş, Güllü İH. Hematopoietik büyüme faktörleri. Yeni gelişmeler ve klinik uygulamaları. Türk Hematol Onkol Derg 1996; 6: 156-64.
75.[A] Yalçın Ş, Güllü İH. Trombopoietin. Türkiye Tıp Derg. Baskıda.
76.[B] Savaş MC, Güllü İH. Life-threatening cardiac arrhythmias during disulfiram-ethanol test reaction: Significance of supervision. Ann Pharmacother 1997; 31: 374-5.
77.[B] Benekli M, Güllü İH. Hippocratic fingers in Behçet’s disease. Postgrad Med J 1997; 73: 575-7.
78.[B] Haznedaroğlu İC, Güllü İH, Dündar S, Kirazlı Ş. The significance and distinct interactions of various growth factors. Aust NZ J Med 1997; 27: 191-2.
79.[B] Yalçın Ş, Güllü İH, Tekuzman G. Ketorolac tromethamine in cancer pain. Acta Oncol 1997; 36: 231-2.
80.[B] Benekli M, Akpek G, Güllü İH, Ruacan Ş, Barışta İ, Ayhan A, Tekuzman G, Fırat D: Small intestinal perforation in a patient with Hodgkin’s disease. J Clin Gastroenterol 1997; 25: 699-701.
81.[A] Güllü İH. Tümör belirleyicileri. Hacettepe Tıp Dergisi 1996; 27: 19-30.
82.[B] Savaş MC, Çelik İ, Benekli M, Güllü İH, Tekuzman G. Renal cell carcinoma presenting as a solitary cervical node metastasis compressing brachial plexus. Nephron 1998; 79: 107-8.
83.[A] Güllü İH, Apraş Ş. Bifosfonatlar. Hacettepe Tıp Dergisi 1996; 27: 63-71.
84.[A] Canter İ, Güllü İH. Genetically engineered antibodies-I. Turk J Hematol Oncol 1998; 8: 37-47.
85.[A] Canter İ, Güllü İH. Genetically engineered antibodies-II. Turk J Hematol Oncol 1998; 8: 103-12.
86.[B] Barışta İ, Çelik İ, Güllü İ, Yalçın Ş. Intrathecal chemotherapy and bone marrow. Leukemia 1997; 11: 1392-3.
87.[A] Çelik İ, Kars A, Apraş Ş, Kansu E, Özışık Y, Güler N, Barışta İ, Güllü İ, Yalçın Ş, Altundağ K, Zengin N, Türker A, Baltalı E, Fırat D. Age as a prognostic parameter in multiple myeloma. Turk J Cancer 1997; 27: 176-82.
88.[B] Haznedaroğlu İ, Büyükaşık Y, Benekli M, Güllü İ. Proposed modification of the “Real Working” Classification of lymphoid neoplasms. J Natl Cancer Inst 1997; 89: 1546.
89.[A] Özaslan E, Zengin N, Güllü İ. Sarılık etyolojisinde Hodgkin Hastalığı. Türkiye Tıp Dergisi 1997; 4: 424-5.
90.[B] Kadayıfçı A, Benekli M, Savaş C, Arslan S, Barışta İ, Güllü İ, Tekuzman G. Multiple lymphomatosis poliposis. J Surg Oncol 1997; 64: 336-40.
91.[A] Zengin N, Çelik İ, Kars A, Barışta İ, Güler N, Özışık Y, Güllü İ, Türker A, Yalçın Ş, Altundağ K, Kansu E, Tekuzman G, Baltalı E, Fırat D. Prognostic significance of age in CLL. Turk J Cancer 1997; 27: 171-4.
92.[B] Çelik İ, Başçıl N, Barışta İ, Güllü İ, Tekuzman G, Fırat D. Primary CNS lymphoma presenting with multiple myeloma like clinical picture. J Neurol Neurosurg Psych 1997; 63: 409-10.
93.[A] Altınbaş N, Güler N, Tekuzman G, Baltalı E, Kars A, Özışık Y, Güllü İ, Barışta İ, Fırat D. Yumuşak doku sarkomlarının dağılımı.Türk Onkoloji Dergisi 1997;12:32-6.
94.[B] Yalçın Ş, Demiroğlu H, Güllü İ, Barışta İ. Lupus nephritis in a patient with ITP. Clin Nephrol 1997; 43: 201-2.
95.[B] Zengin N, Kars A, Kansu E, Özdemir O, Barışta İ, Güllü İ, Güler N, Özışık Y, Dündar S, Fırat D. Comparison of Rai and Binet classifications in CLL. Hematology1997; 2: 125-9.
96.[B] Gündüz M, Ayhan A, Güllü İ, Önerci M, Hoşal AS, Gürsel B, Hoşal IN, Fırat D. nm23 protein expression in larynx cancer and the relationship with metastasis. Eur J Cancer 1997; 33: 2338-42.
97.[B] Kadayıfçı A, Güllü İ, Aka H. Clarithromycin-induced fever in a patient with H. pylori gastritis. Ann Pharmacother 1997; 31: 788.
98.(B) Yalçın Ş, Güllü İ ,Demiroğlu H, Tekuzman G: Acute leukemia during tamoxifen therapy . Medical Oncology 1997, (14) 1: 61-63
99.(B) Kars A.,Çelik İ,Kansu E,Tekuzman G, Özışık Y,Güler N,Barışta İ, Güllü İ, Yalçın Ş, Altundağ K,Zengin N, Türker A,Hayran M, Baltalı E,Fırat D: Maiintenance therapy with alpha interferon following first line VAD in multiple myeloma. Eur J Hemat 1997 59: 100-104
100.[B] Yalçın Ş, Güllü İ, Barışta İ, Tekuzman G, Özışık Y, Çelik İ, Kars A. Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy. Cancer Invest 1998; 16: 297-302.
101.[B] Benekli M, Güllü İ, Haznedaroğlu İ. Ischemic heart disease in Behçet’s syndrome. Rheumatology Int 1998; 17: 251.
102.[B] Güllü İ. Telomerase or telomersyn. Ann Oncol. 1999 Jan; 10 (1):125
103.[B] Yalçın Ş, Güllü İ. Comparison of CEA and CA 125 levels in the ascites and serum of patients with ovarian carcinoma. Cancer Invest 1998; 16: 426-7.
104.[B] Benekli M, Güllü İ, Tekuzman G, Savaş C, Hayran M, Hasçelik G, Fırat D. Circulating intercellular adhesion molecule-1 and E-selectin levels in gastric cancer. British J Cancer 1998; 78: 267-71.
105.[B] Güllü İ, Marangoz S. Plasma thrombospondin levels in patients with colorectal carcinoma. Cancer 1998; 83: 2043-5.
106.[B] Koç Y, Akpek G, Kansu E, Kars A, Tekuzman G, Baltalı E, Güler N, Barışta İ, Güllü İ, Özışık Y, Fırat D. Bolus and continuous infusion mitoxantrone in newly diagnosed adult ALL. Results of two consecutive phase II clinical studies. Cancer Invest 1998; 16: 355-65.
107.(B) Yalçın Ş,Kars A,Özışık Y,Tekuzman G,Özyılkan Ö,Çelik İ,Barışta İ, Güllü İ, Güler N, Baltalı E, Fırat D: VB-CHEP chemotherapy regimen for Non-Hodgkin Lymphomas Eur J Hemat 1998, In press.
108.[B] Güllü İ. Induction of cachexia in mice by a product isolated from the urine of the cachectic cancer patients. Br J Cancer. 1999 Mar;79(9-10): 1620-1.
109.[B] Yalçın Ş, Güllü İ, Tekuzman G, Savaş MC, Fırat D. A comparison of two nonsteroidal antiinflammatory drugs in the treatment of moderate to severe cancer pain. Am J Clin Oncol 1998; 21: 185-8.
110. [B] Marangoz S, Güllü İH. Expresssion of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia. Cancer. 1999 Jun 15;85 (12):2668-9.
111. (B) Güllü İH, Kurdoğlu M. Do human normal somatic cells lack telomerase activity? Gynecol Oncol. 1999 Jul;74(1):147
112. (B) Güllü İH, Marangoz S. Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. 1999 Aug;80(11):1865.
113. (B) Güllü İH, Kurdoğlu M. Effect of acetic acid on telomerase activity in premalignant and malignant cervical lesions. Br J Cancer. 1999 Sep;81(1):186.
114. Yalçın Ş, Tekuzman G, Güllü İ, Kav T, Baltalı E, Kars A, Özışık Y, Güler N, Barışta İ, Çelik İ, Türker A, Altundağ K, Zengin N. Solid tümörlerde kemik iliği metastazlarının klinikopatolojik incelenmesi: 21 vakanın analizi. Türk Hematoloji-Onkoloji Dergisi 1999;9:159-163.
115 Gökçe C, Güllü İ, Barışta İ, Zengin N, Altundağ K, Tekuzman G. Kolorektal Karsinomalı hastalarda serum promatriksmetalloproteinaz-2 düzeyinin prognostik önemi. Türk Hematoloji-Onkoloji Dergisi 2000( Yayına kabul edildi).
116.Altundağ MK, Gökçe C, Güllü Hİ. Bifosfonatların onkolojide kullanımı. Türk Hematoloji-Onkoloji Dergisi 2000;10:234-240.
117.Altundağ MK, Gökçe C, Güllü İH. Larinks kanserlerinde organ koruyucu tedavi. Türk Hematoloji-Onkoloji Dergisi 2001( Yayına kabul edildi).
118. Akata D, Aralasmak A, Ozmen MN, Akhan O, Altundağ K, Güllü İ. US and CT findings of multicentric leiomyosarcomatosis. European Journal of Radiology 1999; 9: 711-714.
119. Usalan C, Özarslan E, Zengin N, Buyükaşık Y, Güllü İH. Acute lymphoblastic leukemia presenting with arthritis in an adult patient. Postgraduate Medical Journal 1999;75:425-427.
.
120. Marangoz S, Güllü İH. Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia. Cancer 1999;15:2668-2669.
121. Barışta İ, Tekuzman G, Yalçın Ş, Güllü İ, Güler N, Özışık Y, Kars A, Çelik İ, Türker A, Altundağ K, Zengin N, Üner A, Baltalı E, Fırat D. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy. Journal of Surgical Oncology 2000;73:12-16.
122.Barışta İ, Baltalı E, Tekuzman G, Kars A, Rucan Ş, Özışık Y, Güler N, Güllü İH, Atahan İL, Fırat D. Primary breast lymphomas- a retrospective analysis of twelve cases. Acta Oncologica 2000;39:135-139.
123. Kurdoğlu M, Güllü İH, Akalın İ. Is there a relationship between tissue inhibitor of metalloproteinase-1 and transforming growth factor-beta 1 with respect to malignant melanoma progression?. Medical Hypotheses 2001;57:238-240.
124.Güllü İH, Kurdoğlu M, Akalın İ. The relation of gelatinase (MMP-2 and –9) expression with distant site metastasis and tumor aggressiveness in colorectal cancer. British Journal of Cancer 2000;82:249.
125.Haznedaroğlu İC, Benekli M, Özcebe O, Savaş MC, Güllü İH, Dündar SV, Kirazlı S. Serum L-selectin and P-selectin levels in lymphomas. Hematologica (Budap) 2000;30:27-30.
126.Akalın İ, Güllü İH, Kurdoğlu M, Marangoz S. Why hepatocellular carcinoma cells are unlikely metastasize: is there a role for tissue inhibitor of metalloproteinase-1?. Medical Hypotheses 2001;57:221-223.
127.Hasegeli Üner A, Abalı H, Engin H, Akyol A, Ruacan Ş, Tan E, Güllü İ, Altundağ K, Güler N. Myasthenia Gravis and lymphphoblastic lymphoma involving the thymus; a rare association. Leukemia and Lymphoma 2001;42:527-531.
128.Cengiz M, Altundağ MK, Zorlu AF, Güllü İH, Özyar E, Atahan İL. Malignancy in Behçet’s disease: Report of thirteen cases and a review of the literature. Clinical Rheumatology 2001;20:239-244.
129.Köklü S, Onat AM, Erol K, Kılıçarslan A, Altundağ MK, Güllü İ. Relapsed prolactinoma 27 years after conventional radiotherapy. American Journal of Clinical Oncology 2001 (Yayına kabul edildi).
130.Karaoğlu A, Altundağ MK, Erman M, Engin H, Güllü İH. Familial asynchronous bilateral primary male breast carcinoma. Journal of Clinical and Experimental Cancer Research 2002(Yayına kabul edildi).
131.Vargel İ, Erdem A, Ertoy D, Pınar A, Erk Y, Altundağ MK, Güllü İ. The effects of growth factors on doxorubicin induced skin necrosis: Documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF. Annals of Plastic Surgery 2002 (Yayına kabul edildi)
132.Abali H, Güllü İH, Engin H, Haznedaroğlu İC, Erman M, Tekuzman G. Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Medical Hypotheses (2002) 59(3),344-348.
KİTAP ve KİTAP BÖLÜMLERİ
1. Güllü İ, Yalçın Ş, Tekuzman T, Kars A, Güler N, Baltalı E, Barışta İ, Fırat D, Bekdik C, Koray Z. Tumor markers in effusions: A comparative study of tumor marker levels in sera and effusion. In: Use of Biomarkers in Assessing Health and Environmental Impacts of Chemical Pollutants. Travis CC (ed). New York, Plenum Press, 1993: 265-71.
2. Güllü İH. Kanser tedavi prensipleri. In: Temel İç Hastalıkları. İliçin G, Biberoğlu K, Ünal S, Süleymanlar G, Akalın S (eds). Ankara, Güneş Kitabevi. Baskıda.
3. Güllü İ, Çelik İ. Kemoterapi El Kitabı. Ankara, Hacettepe Doktorlar Yayınevi, 1996.
KONGRE BİLDİRİLERİ
1. Bakır T, Karacadağ Ş, Telatar H, Güllü İ, Bahşi Y, İlker O. Karaciğer ve akciğer kist hidatik tanısında spesifik IgE'nin kullanılması. I. Allerjik Hastalıklar Sempozyumu, Ankara, 2-4 Haziran, 1983: 14.
2. Özmen F, Güllü İ, Uzun Ö, Karamehmetoğlu A, Oram E. Anstabil anjina pektorisli hastalarda erken prognoz. VI. Ulusal Kardiyoloji Kongresi, Ankara, Türkiye, 23-26 Ekim 1988: 73.
3. Özmen F, Uzun Ö, Güllü İ, Karamehmetoğlu A, Oram E, Uğurlu Ş. Anstabil anjina pektorisli hastalarda sol ventrikül fonksiyonları ve koroner anatomi. VI. Ulusal Kardiyoloji Kongresi, Ankara, Türkiye, 23-26 Ekim 1988: 74.
4. Oto A, Müderrisoğlu H, Güllü İ, Oram E, Karamehmetoğlu A, Uğurlu Ş. Silent myocardial ischemia in Behçet’s disease. Behçet’s Disease Fifth International Conference, Rochester, Minnesota, September 14-15,1989: 35.
5. Güllü İ, Tekuzman G, Kars A, Özışık Y, Güler N, Baltalı E Kansu E, Fırat D. Baş-boyun tümörlerinde cisplatin-bleomycin, 5-fluorouracil ve methotrexate kombine kemoterapisinin değerlendirilmesi. 2.Kemoterapi Kongresi, Kuşadası, İzmir, Türkiye 28 Eylül-3 Ekim, 1990:13.
6. Koç Y, Güllü İ, Akpek G, Akpolat T, Kansu E, Batman F, Telatar H, Kansu T, Zileli T. Vascular involvement in Behçet's disease: Hacettepe University experience. 2nd Mediterranean Congress of Angiology, Antalya, Turkey, 16-21 September 1990, Abstr.Number:162(370).
7. Güllü İ, Müderrisoğlu H, Oto A, Oram E, Oram A, Karamehmetoğlu A, Uğurlu Ş. Silent myocardial ischemia in Behçet's disease. Mediterranean Association of Cardiology and Cardiac Surgery, 4th Annual Meeting, Antalya, Turkey, September 23-27, 1990, Abstr.Number:108.
8. Güllü İ, Tekuzman G, Güler N, Barışta İ, Kars A, Özışık Y, Baltalı E, Kansu E, Fırat D. Baş-boyun tümörlerinde CBMFU kombine kemoterapisinin değerlendirilmesi. IX. Ulusal Kanser Kongresi ve VI. Pediatrik Tümörler Kongresi, İzmir, Türkiye, 2-7 Haziran 1991: 99.
9. Güllü İ, Demirkazık A, Baltalı E, Kars A, Güler N, Barışta İ, Özışık Y, Tekuzman G, Fırat D. Operabl meme kanserlerinde adjuvant kemoterapi olarak L-PAM kullanımı. IX. Ulusal Kanser Kongresi ve VI. Pediatrik Tümörler Kongresi, İzmir, Türkiye, 2-7 Haziran 1991: 184.
10.Akova M, Özcebe O, Güllü İ, Ünal S, Özgen T, Akalın E. SulbactamAmpicillin for the treatment of brain abscesses. 17th International Congress of Chemotherapy, Berlin, Germany, June 23-28, 1991, No: 1326.
11.Akova M, Gür D, Güllü İ, Özcebe O, ünal S, Akalın S, Akalın E.Treatment of diabetic foot infections with Sulbactam Ampicillin. 17th International Congress of Chemotherapy, Berlin, Germany, June 23-28, 1991, No: 1327.
12.Güllü İ, Yalçın Ş, Tekuzman G, Özdemir O, Güler N, Barışta İ, Fırat D, Bekdik C. Effüzyonlarda tümör marker seviyeleri: Serum ve effüzyonlarda tümör marker seviyelerini karşılaştıran bir çalışma. Turk J Nucl Med 1992; 1: 17.
13.Barışta İ, Baltalı E, Güllü İH, Tekuzman G, Kars A, Fırat D, Güler N, Özyılkan Ö. Factors influencing the distribution of metastases in metastatic breast carcinoma. XVIIth Congress of the European Society for Medical Oncology, Lyon, France, November 7-10th 1992. Ann Oncol 1992; 3 (Suppl. 5): 351.
14.Güllü İH, Yalçın S, Barışta İ, Tekuzman G, Kars A, Fırat D. Tumor markers in effusions. A comparative study of tumor marker levels in sera and effusions. XVIIth Congress of the European Society for Medical Oncology, Lyon, France, November 7-10th 1992. Ann Oncol 1992; 3 (Suppl. 5): 569.
15.Güler N, Tekuzman G, Kars A, Baltalı E, Güllü İ, Barışta İ Özyılkan Ö, Akpek G, Fırat D. Opere edilemeyen küçük hücreli olmayan akciğer kanserinde mitomycin, ifosfamide, cisplatin kombine kemoterapisi: Ön rapor. 4.Kemoterapi Kongresi, Bursa, Türkiye, 29-31 Ekim 1992, No: 36.
16.Baltalı E, Kars A, Güler N, Demirkazık A, Tekuzman G, Güllü İ, Özyılkan Ö, Fırat D. Meme kanserli hastaların adjuvant L-PAM, L-PAM + TMX ve TMX sonrası 10 yıllık değerlendirilmesi. 4.Kemoterapi Kongresi, Bursa, Türkiye, 29-31 Ekim 1992, No:39.
17.Güllü İ, Tekuzman G, Barışta İ, Güler N, Özyılkan Ö, Kars A, Özışık Y, Baltalı E, Fırat D. Mide kanserli hastalarda adjuvant kemoterapi: 5-fluorouracil, adriamycin, mitomycin-C kombine tedavisinin değerlendirilmesi. 8.ANKEM Kongresi, Antalya, Türkiye, 22-28 Mayıs,1993, No: 75.
18.Kiraz S, Baltalı E, Barışta İ, Güler N, Güllü İH, Kars A, Tekuzman G, Fırat D. Comparison of salvage chemotherapy protocols ifosfamide+mesna+etoposide (VP16) versus ifosfamide+mesna+epirubicin in cases with stage IV breast carcinoma. 18th. International Congress of Chemotherapy, Stockholm-Sweden, June 27th-July 2nd 1993, sayfa 174, P310 (043).
19.Güllü İH, Tekuzman G, Barışta İ, Güler N, Kars A, Özışık Y, Özyılkan Ö, Baltalı E, Kansu E, Fırat D. 5-Fluorouracil, adriamycin and mitomycin-C combination chemotherapy for advanced gastric carcinoma. 18th. International Congress of Chemotherapy, Stockholm-Sweden, June 27th-July 2nd 1993, sayfa 247, P747 (097).
20.Güler N, Tekuzman G, Kars A, Baltalı E, Güllü İH, Barışta İ, Özyılkan Ö, Fırat D. Mitomycin, ifosfamide and cisplatin combined chemotherapy in the treatment of inoperable non-small cell lung cancer: A preliminary report. 18th. International Congress of Chemotherapy, Stockholm-Sweden, June 27th-July 2nd 1993, sayfa 385, P1573 (221).
21.Güllü İH, Yalçın Ş, Tekuzman G, Barışta İ, Kars A, Güler N, Baltalı E, Özyılkan Ö, Kansu E, Fırat D. Malign hastalıklarda tümör işaretleyicilerinin karşılaştırmalı tayini. X.Ulusal Kanser Kongresi, İstanbul-Türkiye, 3-7 Mayıs 1993, sayfa 4, a.
22.Güllü İH, Tekuzman G, Barışta İ, Güler N, Özyılkan Ö, Kars A, Özışık Y, Baltalı E, Akpek G, Fırat D. Mide kanserli hastalarda adjuvant kemoterapi: 5-Fluorouracil, adriamycin, mitomycin-C kombine kemoterapisinin değerlendirilmesi. X.Ulusal Kanser Kongresi, İstanbul-Türkiye, 3-7 Mayıs 1993, sayfa 12, a.
23.Baltalı E, Kars A, Tekuzman G, Güllü İH, Enünlü T, Özyılkan Ö, Fırat D. Meme kanserli hastaların adjuvant L-PAM+TMX ve TMX sonrası 10 yıllık değerlendirilmesi. X. Ulusal Kanser Kongresi, İstanbul- Türkiye, 3-7 mayıs 1993, sayfa 19, a.
24.Kiraz S, Baltalı E, Barışta İ, Güler N, Güllü İH, Kars A, Tekuzman G, Fırat D. Evre IV meme karsinomlu olgularda ifosfamid+mesna+etoposid ve ifosfamid+mesna+epirubicin salvage kemoterapi protokollerinin karşılaştırılması. X.Ulusal Kanser Kongresi, İstanbul-Türkiye, 3-7 Mayıs 1993, sayfa 20, a.
25.Turgut M, Baltalı E, Barışta İ, Güllü İH, Güler N, Kars A, Tekuzman G, Fırat D, Akpek G. Evre IV Meme Karsinomlu Olgularda CEF ve CNF Kemoterapi Protokollerinin Değerlendirilmesi. X.Ulusal Kanser Kongresi, İstanbul-Türkiye, 3-7 Mayıs 1993, sayfa 20, a.
26.Kars A, Tekuzman G, Özyılkan Ö, Güler N, Baltalı E, Barışta İ, Güllü İH, Akpek G, Kansu E, Ruacan Ş, Fırat D. Non-Hodgkin Lenfoma'da (NHL) MINE Kemoterapisi. X.Ulusal Kanser Kongresi, İstanbul-Türkiye, 3-7 Mayıs 1993, sayfa 35, a.
27.Güler N, Baltalı E, Kars A, Tekuzman G, Güllü İ, Barışta İ, Fırat D. Meme kanserinde klinik izlemde CEA ve CA 15-3’ün önemi. X.Ulusal Kanser Kongresi, İstanbul-Türkiye, 3-7 Mayıs 1993, sayfa 65, a.
28.Kiraz S, Baltalı E, Barışta İ, Güler N, Güllü İH, Kars A, Tekuzman G, Fırat D. Comparison of salvage chemotherapy protocols ifosfamide+mesna+etoposide (VP16) versus ifosfamide+ mesna+epirubicin in cases with stage IV breast carcinoma. 7th European Conference on Clinical Oncology and Cancer Nursing, Jerusalem-Israel, November 14-18th 1993. Eur J Cancer 1993; 29A (Suppl 6): S79 (411a).
29.Kars A, Tekuzman G, Özyılkan Ö, Güler N, Baltalı E, Barışta İ, Güllü İH, Akpek G, Kansu E, Ruacan Ş, Fırat D. MINE regimen in non-Hodgkin's lymphoma (NHL). 7th European Conference on Clinical Oncology and Cancer Nursing, Jerusalem-Israel, November 14-18th 1993. Eur J Cancer 1993; 29A (Suppl 6): S176 (977a).
30.Haznedaroğlu Ş, Güllü İH, Baltalı E, Haznedaroğlu İ, Barışta İ, Tekuzman G, Güler N, Altınbaş M, Kars A, Fırat D. The significance of CEA and CA 19-9 in the diagnosis and follow-up of the gastrointestinal malignancies. 10th Congress of Gastroenterology, Los Angeles, California-USA, Oct 2th-7th 1994, 341p.
31.Yalçın Ş, Savaş MC, Güllü İH, Tekuzman G, Barışta İ, Fırat D. Şiddetli kanser ağrısında oral ketoralak trometaminin etkinliği ve dipiron ile karşılaştırılması. Türk Farmakoloji Derneği 12. Ulusal Kongresi, Tekirova, Antalya, 31 Ekim-4 Kasım 1994, P4-9.
32.Turgut M, Baltalı E, Barışta İ, Güllü İH, Güler N, Kars A, Tekuzman G, Özyılkan Ö, Akpek G, Fırat D. CEF (cyclophosphamide, epirubicin, fluorouracil) and CNF (cyclophosphamide, mitoxantrone, fluorouracil) chemotherapy protocols in stage IV breast carcinoma. XVI.International Cancer Congress, New Delhi-India, Oct 30th-Nov 5th 1994, sayfa 17:OPBR5-01.
33.Tekuzman G, Barışta İ, Baltalı E, Güllü İH, Özyılkan Ö, Güler N, Kars SA, Akpek G, Fırat D. Methotrexate, mitoxantrone, mitomycin-C (MMM) salvage chemotherapy in metastatic breast carcinoma. XVI.International Cancer Congress, New Delhi-India, Oct 30th-Nov 5th 1994, sayfa 159: PSBR4-22.
34.Baltalı E, Güler N, Fırat D, Kars A, Özyılkan Ö, Barışta İ, Güllü İH, Tekuzman G, Akpek G. Mitoxantrone, fluorouracil and leucovorin combined chemotherapy in patients with metastatic breast carcinoma. XVI.International Cancer Congress, New Delhi-India, Oct 30th-Nov 5th 1994, sayfa 159: PSBR4-23.
35.Fırat D, Baltalı E, Güler N, Kars A, Tekuzman G, Güllü İH, Barışta İ, Öner Z, Sayek İ, Çakmakçı M, Özyılkan Ö, Akpek G. CNF combination as neoadjuvant chemotherapy in locally advanced (stage 3) breast cancer patients. XVI.International Cancer Congress, New Delhi-India, Oct 30th-Nov 5th 1994, sayfa 159: PSBR4-24.
36.Barışta İ, Tekuzman G, Güllü İH, Özyılkan Ö, Özışık Y, Güler N, Kars A, Baltalı E, Kansu E, Fırat D. Primary non-Hodgkin's lymphoma of the stomach: diagnostic findings and treatment results of 40 cases. XVI.International Cancer Congress, New Delhi-India, Oct 30th-Nov 5th 1994, sayfa 179: PSGI3-25.
37.Güllü İH, Yalçın Ş, Tekuzman G, Barışta İ, Çelik İ, Alkış N, Güler A, Kars A, Baltalı E, Kansu E, Fırat D. High dose ifosfamide by infusion with mesna in advanced sarcomas (A phase II study). XVI. International Cancer Congress New Delhi-India, Oct 30th-Nov 5th,1994, sayfa 252: PSBO2-07.
38.Güllü İH, Tekuzman G, Altunbaş M, Barışta İ, Çelik İ, Alkış N, Güler N, Kars A, Baltalı E, Yalçın Ş, Sungur A, Fırat D. Phase II study of procarbazine, CCNU and vincristine (PCV) combination chemotherapy in the treatment of primary brain tumors. XVI.International Cancer Congress, New Delhi-India, Oct 30th-Nov 5th 1994, sayfa 254: PSBT1-03.
39.Haznedaroğlu Ş, Güllü İH, Baltalı E, Barışta İ, Tekuzman G, Güler N, Kars A, Fırat D. Gastrointestinal sistem kanserlerinde tümör belirleyicilerinin klinik ve tedavideki önemi. XI. Ulusal Türk Gastroenteroloji Kongresi, Antalya- Türkiye 1994, 425, a.
40.Benekli M, Güllü İH, Savaş C, Altundağ MK, Kars A, Güler N, Tekuzman G, Kansu E, Fırat D. Tumor lysis syndrome following intratecal methotrexate. Fifth International Congress on Anti-cancer Chemotherapy, Paris-France, Jan 31st-Feb 3rd, 1995, sayfa 196, P131.
41.Benekli M, Savaş MC, Güllü İH, Akpek G, Kars A, Güler N, Kansu E, Tekuzman G, Fırat D. Tumor lysis syndrome following single dose mitoxantrone. Fifth International Congress on Anti-cancer Chemotherapy, Paris-France, Jan 31st-Feb 3rd, 1995, sayfa 196, P132.
42.Güllü İH, Çelik İ, Tekuzman G, Güler N, Barışta İ, Alkış N, Yalçın Ş, Benekli M, Kars A, Baltalı E, Kansu E, Fırat D: A phase II study of procarbazine, CCNU, vicristine combination in the treatment of brain tumors. Fifth International Congress on Anti-cancer Chemotherapy, Paris-France, Jan 31st-Feb 3rd, 1995, sayfa 197, P133.
43.Baltalı E, Güler N, Kars A, Enünlü T, Tekuzman G, Fırat D, Onat D, Atahan L, Güllü İH, Barışta İ, Özyılkan Ö. CMF of CMF+RT as adjuvant therapy in patients with stage I-III A breast carcinoma. Fifth International Congress on Anti-Cancer Chemotherapy, Paris-France, Jan 31st-Feb 3rd 1995, sayfa 197, P140.
44.Baltalı E, Güler N, Tekuzman G, Güllü İH, Barışta İ, Öner Z, Sayek İ, Akpek G, Fırat D. CNF combination as neoadjuvant chemotherapy in locally advanced breast cancer patients. Fifth International Congress on Anti-cancer Chemotherapy, Paris-France, Jan 31st-Feb 3rd, 1995, sayfa 198, P141.
45.Altınbaş M, Güler N, Enünlü T, Tekuzman G, Alkış N, Güllü İH, Barışta İ, Kars A, Baltalı E, Fırat D. Opere beyin tümörleri: Procarbazine-CCNU-vincristin kemoterapi sonuçları. XI. Ulusal Kanser Kongresi, Antalya, Mayıs 1995. Türk Onkol Derg 1995;10: sayfa 34, A-33.
46.Baltalı E, Güler N, Kars A, Tekuzman G, Güllü İH, Barışta İ, Öner Z, Sayek İ, Çakmakçı M, Özyılkan Ö, Akpek G, Fırat D. Lokal ilerlemiş meme kanserinde neoadjuvant cyclophosphamide, mitoxantrone, fluorouracil kombine kemoterapisi. XI. Ulusal Kanser Kongresi, Antalya, Mayıs 1995. Türk Onkol Derg 1995;10: sayfa 55, B-115.
47.Baltalı E, Güler N, Fırat D, Kars A, Tekuzman G, Özyılkan Ö, Barışta İ, Güllü İH, Akpek G. Metastatik meme kanserinde mitoxantrone, 5-Fluorouracil ve rescuvolin kombine kemoterapisi. XI. Ulusal Kanser Kongresi, Antalya, Mayıs 1995. Türk Onkol Derg 1995;10: sayfa 56, B-121.
48.Yalçın Ş, Kars A, Özyılkan Ö, Tekuzman G, Güler N, Güllü İH, Barışta İ, Akpek G, Çelik İ, Baltalı E, Özışık Y, Fırat D. Agresif Hodgkin dışı lenfomalarda vinkristin-bleomisin/siklofosfamid -adriamisin-etoposit-prednizolon kombine kemoterapisi. XI. Ulusal Kanser Kongresi, Antalya, Mayıs 1995. Türk Onkol Derg 1995;10: sayfa 64, B-147.
49.Altınbaş M, Güler N, Tekuzman G, Baltalı E, Kars A, Özışık Y, Güllü İH, Barışta İ, Fırat D. Yumuşak doku sarkomlarının dağılımı: Hacettepe Tıp Fakültesi sonuçları. XI. Ulusal Kanser Kongresi, Antalya, Mayıs 1995. Türk Onkol Derg 1995;10: sayfa 98, D-280.
50.Güllü İH, Yalçın Ş, Tekuzman G, Barışta İ, Çelik İ, Güler N, Kars A, Zengin N, Baltalı E, Fırat D. İleri Evre Refrakter Sarkomlarda İfosfamid/Mesna Kemoterapisi: Bir Faz II Çalışma. XI. Ulusal Kanser Kongresi, Antalya, Mayıs 1995. Türk Onkol Derg 1995;10: sayfa 99, D-286.
51.Yalçın Ş, Kars A, Özyılkan Ö, Tekuzman G, Güler N, Güllü İH, Çelik İ, Barışta İ, Baltalı E, Özışık Y, Fırat D. VB-CHEP chemotherapy regimen for agressive nonHodgkin's lymphomas; a preliminary report. 19th International Congress of Chemotherapy, Montreal, Quebec, Canada, July 16-21th 1995. Can J Infect Dis 1995; 6 (Suppl C): 1077.
52.Yalçın Ş, Güllü İH, Tekuzman G, Kars A, Çelik İ, Barışta İ, Güler N, Zengin N, Baltalı E, Fırat D. Etoposide and ifosfamide in advanced refractory sarcomas: a phase II study. 19th International Congress of Chemotherapy, Montreal, Quebec, Canada, July 16-21th 1995. Can J Infect Dis 1995; 6 (Suppl C): 2032.
53.Yalçın Ş, Savaş C, Güllü İH, Tekuzman G, Barişta İ, Zengin N, Fırat D. Efficacy of oral ketorolac tromethamine compared with dypiron in patients suffering cancer pain. 19th International Congress of Chemotherapy, Montreal, Quebec, Canada, July 16-21th 1995. Can J Infect Dis 1995; 6 (Suppl C): 2215.
54.Yalçın Ş, Güler N, Kansu E, Ertenli İ, Güllü İ, Kars A, Akpek G, Barışta İ, Tekuzman G, Baltalı E, Fırat D. Granulocyte-colony stimulating factor (G-CSF) administration for chemotherapy induced neutropenia. The European Cancer Conference (ECCO 8), Paris, France, Oct 29-Nov 2nd 1995. Eur J Cancer 1995; 31A (Suppl 5): S125 (591).
55.Güler N, Baltalı E, Kars A, Özışık Y, Enünlü T, Tekuzman G, Özyılkan Ö, Onat D, Güllü İ, Barışta İ, Fırat D. CMF or CMF+RT as adjuvant therapy in patients with stage I-IIIA breast carcinoma. The European Cancer Conference (ECCO 8), Paris, France, Oct 29-Nov 2nd 1995. Eur J Cancer 1995; 31A (Suppl 5): S16 (70).
56.Altundağ MK, Çelik İ, Güllü İ, Tekuzman G, Fırat D. A case of intrathoracic plasmocytoma presenting as an extrapleural mass with IgA myeloma. XIIth Meeting of the International Society of Haematology (European & African Division), September 3-8, İstanbul-Turkiye. Turk J Haematol 1995 (Suppl 1); 14: 783.
57.Çelik İ, Apraş Ş, Güler N, Kars A, Barışta İ, Güllü İ, Kansu E, Fırat D. Hypercalcemia leading to acute pancreatitis in a relapsed multiple myeloma patient. XIIth Meeting of the International Society of Haematology (European & African Division), September 3-8, İstanbul-Turkiye. Turk J Haematol 1995 (Suppl 1); 14: 785.
58.Çelik İ, Başçıl N, Türker A, Barışta İ, Güllü İH, Kars A, Tekuzman G, Fırat D. Primary central nervous system lymphoma simulating multiple myeloma. XIIth Meeting of the International Society of Haematology (European & African Division), September 3-8, İstanbul-Turkiye. Turk J Haematol 1995 (Suppl 1); 14: 786.
59.Altundağ MK, Baltalı E, Güllü İ, Barışta İ, Çelik İ, Tekuzman G, Zengin N, Fırat D. Single-dose pamidronate use in patients with malignant hypercalcemia. Fifth International Conference on Anticancer Research, Corfu-Greece, October 17-22nd 1995. Anticancer Res 1995; 15 (5A): p1718 (227).
60. Topeli A, Güllü İ, Çelik İ, Barışta İ, Yalçın Ş, Kars A, Tekuzman G, Baltalı E, Özışık Y, Güler N, Hoşal Ş, Önerci M, Fırat D. Efficacy of neoadjuvant and adjuvant chemotherapy in head and neck cancer. Fifth International Conference on Anticancer Research, Corfu-Greece, October 17-22nd 1995. Anticancer Res 1995; 15 (5A): p1720 (232).
61.Çelik İ, Kars A, Barışta İ, Güllü İ, Güler N, Kansu E, Tekuzman G, Baltalı E, Fırat D. Interferon treatment in multiple myeloma after remission induction: Does it prolong survival? Fifth International Conference on Anticancer Research, Corfu-Greece, October 17-22nd 1995. Anticancer Res 1995; 15 (5A): p1721 (234).
62.Kiraz S, Baltalı E, Güler N, Barışta İ, Benekli M, Çelik İ, Güllü İH, Kars A, Tekuzman G, Fırat D: Ifosfamide, mesna and epirubicin in advanced breast cancer. Sixth International Congress on Anti-Cancer Treatment, February 6-9, 1996, Paris-France, p: 155, 406ter.
63.Başçıl N, Çelik İ, Özyılkan Ö, Yalçın Ş, Güllü İ, Kars A, Usalan C, Tekuzman G, Fırat D. Alternative ifosfamide containing salvage regimen for recurrent or metastatic hemangiopericytoma. Sixth International Congress on Anti-Cancer Treatment, February 6-9, 1996, Paris-France, p: 173, 480.
64.Benekli M, Çelik İ, Kadayıfçı A, Tekuzman G, Savaş MC, Güllü İH, Barışta İ, Arslan S, Fırat D: Multiple lymphomatous polyposis. Sixth International Congress on Anti-Cancer Treatment, February 6-9, 1996, Paris-France, p: 218, 660.
65.Benekli M, Savaş MC, Güllü İH, Altundağ MK, Kadayıfçı A, Güler N, Kars A, Tekuzman G, Kansu E, Fırat D. İntratekal metotreksat sonrası gelişen tümör lizis sendromu. XXIV Ulusal Hematoloji Kongresi, 11-14 Nisan 1996, 291.
66.Çelik İ, Kars A, Kansu E, Özışık Y, Güler N, Barışta İ, Güllü İH, Yalçın Ş, Altundağ K, Zengin N, Tekuzman G, Baltalı E, Fırat D: Vincristine, adriamycine and dexamethasone (VAD) chemotherapy with or without interferon-a2b maintenance in stage II and III multiple myeloma. Tenth Mediterranean Congress of Chemotherapy, Antalya, Turkey; October 20-25, 1996, p 153 (314).
67.Yalçın Ş, Güllü İH, Tekuzman G, Barışta İ, Özışık Y, Çelik İ, Kars A, Güler N, Fırat D: Treatment of refractory soft tissue sarcomas with etoposide and ifosfamide. Tenth Mediterranean Congress of Chemotherapy, Antalya, Turkey; October 20-25, 1996, p 184 (317).
68.Güllü İH, Benekli M, Savaş MC, Hasçelik G, Barışta İ, Altundağ MK, Zengin N, Kars A, Tekuzman G, Fırat D: Serum CYFRA 21-1 in lung cancer. 21st ESMO Congress, Vienna, Austria; November 1-5, 1996. Ann Oncol 1996;7 (suppl 5):480.
69.Güllü İH, Topeli A, Çelik İ, Barışta İ, Hoşal Ş, Önerci M, Tekuzman G, Baltalı E, Özışık Y, Fırat D: Cisplatin, 5-fluorouracil and folinic acid (CFF) for neoadjuvant chemotherapy of head and neck cancer. 21st ESMO Congress, Vienna, Austria; November 1-5, 1996. Ann Oncol 1996; 7 (suppl 5): 207.
70.Aykan NF, Üskent N, Yaylacı M, Güllü İH, Çamlıbel S, Ertürk N, Dişçi R, Onat H: 5-fluorouracil (5-FU) plus interferon (IFN) alfa-2B versus 5-fluorouracil plus folinic acid (FA) in advanced colorectal cancer; Same efficacy but different toxicity. 21st ESMO Congress, Vienna, Austria; November 1-5, 1996. Ann Oncol 1996; 7 (suppl 5): 195.
71.Kars A, Çelik İ, Kansu E, Özışık Y, Güler N, Barışta İ, Güllü İH, Yalçın Ş, Altundağ K, Zengin N, Tekuzman G, Baltalı E, Fırat D: Vincristine, adriamycine and dexamethasone (VAD) chemotherapy with or without interferon-a2b maintenance in multiple myeloma. American Society of Hematology 38th Annual Meeting, Orlando, Florida; December 6-10, 1996. Blood 1996; 88 (10 suppl 1): 2206 (3609).
72.Haznedaroğlu İC, Benekli M, Savaş MC, Güllü İH, Dündar SV, Kirazlı Ş. Serum L-selectin and P-selectin levels in lymphomas. ECCO 9, The European Cancer Conference, Hamburg, Germany; September 14-18, 1997. Eur J Cancer 1997; 33 (suppl 8):1212.
73.Benekli M, Savaş MC, Güllü İH, Hasçelik G, Altundağ MK, Zengin N, Çelik İ, Yalçın Ş, Barışta İ, Güler N, Özışık Y, Kars A, Baltalı E, Kansu E, Tekuzman G, Fırat D. Akciğer kanserlerinde serum CYFRA 21-1 düzeyleri. XII. Ulusal Kanser Kongresi, Antalya, Turkey, April 23-26, 1997: P27.
74.Ören H, Baltalı E, Özışık Y, Güler N, Kars A, Barışta İ, Güllü İ, Tekuzman G, Fırat D, Ayhan A. Meme kanserli hastalarda tamoksifen kullanımına bağlı gelişen jinekolojik komplikasyonlar. XII. Ulusal Kanser Kongresi, Antalya, Turkey, April 23-26, 1997: P150.
75.Güler N, Baltalı E, Altundağ K, Tekuzman G, Güllü İ. Metastatik meme karsinomlu hastalarda taxol tedavisi sonuçları. XII. Ulusal Kanser Kongresi, Antalya, Turkey, April 23-26, 1997: P177.
76.Zengin N, Kars A, Özışık Y, Ruacan Ş, Kansu E, Türker A, Altundağ MK, Yalçın Ş, Çelik İ, Güllü İH, Barışta İ, Güler N, Baltalı E, Tekuzman G, Fırat D. Alökemik lökemia kütis. Olgu sunumu. XII. Ulusal Kanser Kongresi, Antalya, Turkey, April 23-26, 1997: P207.
77.Yalçın Ş, Güler N, Kansu E, Ertenli İ, Akpek G, Kars A, Güllü İH, Barışta İ, Tekuzman G, Fırat D. Kemoterapiye bağlı nötropenide granülosit-koloni stimüle edici faktör uygulaması. XII. Ulusal Kanser Kongresi, Antalya, Turkey, April 23-26, 1997: P210.
78.Haznedaroğlu İC, Benekli M, Güllü İH, Savaş MC, Büyükaşık Y, Dündar SV, Kirazlı Ş. Lenfomalarda serum L-selektin ve P-selektin düzeyleri. XII. Ulusal Kanser Kongresi, Antalya, Turkey, April 23-26, 1997: P219.
79.Zengin N, Kars A, Kansu E, Barışta İ, Güllü İH, Güler N, Özışık Y, Çelik İ, Yalçın Ş, Altundağ MK, Baltalı E, Tekuzman G, Fırat D. Kronik lenfositik lösemide serum immünglobulin düzeyleri. XII. Ulusal Kanser Kongresi, Antalya, Turkey, April 23-26, 1997: P253.
80.Çelik İ, Kars A, Kansu E, Tekuzman G, Özışık Y, Güler N, Barışta İ, Güllü İH, Yalçın Ş, Altundağ MK, Zengin N, Türker A, Baltalı E, Fırat D. Evre II-III multiple myelomda VAD kemoterapisi ve sonrasında interferon-alfa2b idame tedavisi. XII. Ulusal Kanser Kongresi, Antalya, Turkey, April 23-26, 1997: P261.
81.Yalçın Ş, Kars A, Tekuzman G, Alkış N, Zengin N, Özışık Y, Güler N, Güllü İH, Barışta İ, Baltalı E, Fırat D. Kolorektal karsinomlarda adjuvant 5-fluorourasil/folinik asit kemoterapisi: 6 siklus / 12 siklus karşılaştırılması. XII. Ulusal Kanser Kongresi, Antalya, Turkey, April 23-26, 1997: P303.
82.Benekli M, Güllü İH, Tekuzman G, Savaş MC, Hayran M, Hasçelik G, Barışta İ, Güler N, Özışık Y, Kars A, Altundağ MK, Zengin N, Çelik İ, Yalçın Ş, Baltalı E, Kansu E, Fırat D. Mide kanserlerinde serum ICAM-1 ve E-selektin düzeyleri. XII. Ulusal Kanser Kongresi, Antalya, Turkey, April 23-26, 1997: P308.
83.Güllü İH, Benekli M, Savaş MC, Tekuzman G, Hasçelik G, Barışta İ, Güler N, Özışık Y, Kars A, Altundağ MK, Zengin N, Çelik İ, Yalçın Ş, Baltalı E, Kansu E, Fırat D. Baş-boyun tümörlerinde serum ICAM-1 ve E-selektin düzeyleri. XII. Ulusal Kanser Kongresi, Antalya, Turkey, April 23-26, 1997: P400.
84.Güllü İH, Benekli M, Tekuzman G, Barışta İ, Fırat D. Serum levels of Icam-1 and E-selectin in gastric cancer. 33rd Annual Meeting of ASCO, Denver, CO; May 17-20, 1997. J Clin Oncol 1997; 16: 1576.
85.Baltalı E, Güler N, Kars A, Tekuzman G, Öner Z, Sayek İ, Çakmakçı M, Fırat D, Onat DA, Atahan L, Barışta İ, Güllü İ. CNF protocol as neoadjuvant chemotherapy in locally advanced breast carcinoma. 2nd Balkan Congress of Oncology, İzmir, Turkey; September 10-14, 1998. J Balkan Union Oncology 1997; 3 (Suppl A): P124.
86.Altundağ MK, Baltalı E, Güler N, Güllü İ, Çelik İ, Barışta İ, Kars A, Özışık Y, Zengin N, Yalçın Ş, Tekuzman G, Fırat D. The results of intravenous pamidronate use in patients with malignant hypercalcemia. 2nd Balkan Congress of Oncology, İzmir, Turkey; September 10-14, 1998. J Balkan Union Oncology 1997; 3 (Suppl A): P132.
87.Çelik İ, Kars A, Apraş Ş, Kansu E, Tekuzman G, Özışık Y, Güler N, Barışta İ, Güllü İ, Yalçın Ş. Age as a prognostic parameter in multiple myeloma. 2nd Balkan Congress of Oncology, İzmir, Turkey; September 10-14, 1998. J Balkan Union Oncology 1997; 3 (Suppl A): P236.
88. .Güllü İ, Zengin N, Altundağ MK, Avşar B, Aksakal A, Kirazlı Ş, Tekuzman G. Kolorektal kanserlerde DR-70TM tümör belirliyicisinin tanısal değeri. I. Ulusal İç Hastalıkları Kongresi, Antalya, 3-7 Kasım, 1999. Özet kitabı P 107.
89. Altundağ MK, Çelik İ, Güllü İH, Güler N, Kars A, Türker A, Özışık Y, Baltalı E, Altundağ Ö, Erman M, Abalı H, Tekuzman G. Hacettepe Medikal Onkoloji Bölümünde takip edilen renal hücreli karsinomlu hastaların tedavi sonuçları. II. Ulusal İç Hastalıkları Kongresi, Antalya, 20-24 Eylül, 2000. Özet kitabı P130.
90. Altundağ MK, Güllü İH, Altundağ Ö, Yalçın Ş, Tekuzman G, Özyar E, Akyol F, Hoşal Ş, Yücel T, Kya S. İleri evre larinks ve hipofarinks kanserlerinde indüksiyon (kemoterapi+radyoterapi) tedavisiyle organ korunması. II. Ulusal İç Hastalıkları Kongresi, Antalya, 20-24 Eylül, 2000. Özet kitabı P118.
91. Gökçe C, Güllü İH, Barışta İ, Zengin N, Altundağ MK, Altundağ Ö, Akçay A, Marangoz S, İzgi C, Tekuzman G. Serum Promatriksmetalloproteinaz-2 (proMMP-2) düzeyinin kolorektal karsinomadaki değeri. II. Ulusal İç Hastalıkları Kongresi, Antalya, 20-24 Eylül, 2000. Özet kitabı P119.
92. Abalı H, Altundağ MK, Güllü İH, Altundağ Ö, Çelik İ, Güler N, Kars A, Türker A, Özışık Y, Baltalı E, Tekuzman G. Hacettepe Medikal Onkoloji Bölümünde takip edilen özefagus kanserli hastaların tedavi sonuçları. II. Ulusal İç Hastalıkları Kongresi, Antalya, 20-24 Eylül, 2000. Özet kitabı P131.
93. Vargel İ, Erdem A, Erk Y, Altundağ K, Ertoy D, Pınar A, Güllü İ. Doksorubisin ekstravazasyonunda oluşabilecek doku nekrozunun GM-CSF, GCSF yada serum fizyolojik ile profilaktik tedavisi. XXII.Ulusal Türk Plastik Rekonstrüktif ve Estetik Cerrahi Derneği Kongresi, İzmir, 27 Eylül-1 Ekim, 2000. Özet Kitabı, S100.
94. Altundağ Ö, Güllü İ, Barişta İ, Altundağ K, Zengin N, Erman M, Öksüzoğlu B, Çelik İ, Yalçın Ş, Türker A, Güler N, Özışık Y, Kars A, Kansu E, Tekuzman G. Refrakter ve relaps Hodgkin hastalığı ve non-Hodgkin lenfomalı hastalarda oral PECC kombinasyon kemoterapisi sonuçları. XIV. Ulusal Kanser Kongresi, İstanbul, 30 Nisan-4 Mayıs-2001. Özet kitabı SB-17,sayfa 93.
95. Vargel İ, Güllü İ, Altundağ MK, Zengin N, Tekuzman G. Serum matriksmetalloprpteinaz-2 (proMMP-2) düzeyinin baş-boyun bölgesi deri karsinomlarındaki değeri. XIV. Ulusal Kanser Kongresi, İstanbul, 30 Nisan-4 Mayıs-2001. Özet kitabı PO-4,sayfa 140.
96. Vargel İ, Güllü İ, Altundağ MK, Zengin N, Tekuzman G. Serum matriksmetalloprpteinaz-2 (proMMP-2) düzeyinin baş-boyun bölgesi deri karsinomlarındaki değeri. XIV. Ulusal Kanser Kongresi, İstanbul, 30 Nisan-4 Mayıs-2001. Özet kitabı PO-4,sayfa 140.
97. Güllü İH, Gökçe C, Barışta İ, Zengin N, Altundağ MK, Altundağ Ö, Akçay A, Marangoz S, İzgi C, Tekuzman G. Serum matriksmetalloproteinaz-2 (pro-MMP-2) düzeyinin kolorektal karsinomadaki değeri. XIV. Ulusal Kanser Kongresi, İstanbul, 30 Nisan-4 Mayıs-2001. Özet kitabı PO-4,sayfa 141.
98. Altundağ MK, Yalçın Ş, Baltalı E, Özışık Y, Güler N, Çelik İ, Altundağ Ö, Karaoğlu A, Zengin N, Güllü İ, Tekuzman G. Premenapozal opere Evre I-IIIA meme kanserli hastlarda adjuvan Siklofosfamid-Metotreksat-Fluorourasi (CMF) sonuçlarının incelenmesi. XIV. Ulusal Kanser Kongresi, İstanbul, 30 Nisan-4 Mayıs-2001. Özet kitabı PO-4,sayfa 141.
99. Altundağ MK, Altundağ Ö, Yalçın Ş, Abalı H, Karaoğlu A, Çelik İ, Güler N, Güllü İ, Özışık Y, Kars A, Türker A, Baltalı E, Tekuzman G. Hacettepe Tıp Fakültesi Medikal Onkoloji bölümünde takip edilen operabl mide kanserli hastaların klinik değerlendirilmesi. XIV. Ulusal Kanser Kongresi, İstanbul, 30 Nisan-4 Mayıs-2001. Özet kitabı PO-4,sayfa 142.
100. Altundağ MK, Altundağ Ö, Yalçın Ş, Abalı H, Çelik İ, Güler N, Güllü İ, Özışık Y, Kars A, Türker A, Baltalı E, Tekuzman G. Hacettepe Tıp Fakültesi Medikal Onkoloji bölümünde takip edilen ileri evre mide kanserli hastaların klinik değerlendirilmesi. XIV. Ulusal Kanser Kongresi, İstanbul, 30 Nisan-4 Mayıs-2001. Özet kitabı PO-4,sayfa 142.
101. Pınar T, Akdur R, Tunçbilek A, Altundağ Ö, Altundağ K, Güllü İ. Baş-boyun tümörleri ve meslek ilişkisi. XIV. Ulusal Kanser Kongresi, İstanbul, 30 Nisan-4 Mayıs-2001. Özet kitabı PO-4,sayfa 143.
102. Öztürk MA, Altundağ K, Barışta İ, Türker A, Altundağ Ö, Erman M, Yalçın Ş, Çelik İ, Güllü İ, Güler N, Özışık Y, Kars A, Kansu E, Baltalı E, Tekuzman G. Refrakter veya relaps non-Hodgkin lenfomalı hastlarda modifiye ESHAP kurtarma kemoterapisi: Hacettepe Üniversitesi deneyimi. XIV. Ulusal Kanser Kongresi, İstanbul, 30 Nisan-4 Mayıs-2001. Özet kitabı PO-4,sayfa 143.
103. Cengiz M, Altundağ K, Zorlu AF, Güllü İ, Özyar E, Atahan L. Behçet hastalarında gelişen malignansiler. XIV. Ulusal Kanser Kongresi, İstanbul, 30 Nisan-4 Mayıs-2001. Özet kitabı PO-4,sayfa 144.
104. Vargel İ, Erdem A, Erk Y, Altundağ K, Ertoy D, Pınar A, Güllü İ. Doksorubisin ekstravazasyonunda oluşabilecek doku nekrozunun GM-CSF, G-CSF veya serum fizyolojik ile profilaktik tedavisi. XIV. Ulusal Kanser Kongresi, İstanbul, 30 Nisan-4 Mayıs-2001. Özet kitabı PO-2,sayfa 162.
105. Altundağ Ö, Altundağ MK, Engin H, Güler N, Yalçın Ş, Akyol F, Güllü İ, Yavaş Ö, Öğretmenoğlu O, Yücel T, Tekuzman G. Hacettepe Tıp Fakültesi Medikal Onkoloji bölümünde takip edilen sino-nazal malign melanomların klinik değerlendirilmesi. XIV. Ulusal Kanser Kongresi, İstanbul, 30 Nisan-4 Mayıs-2001. Özet kitabı PO-3,sayfa 227.
106. Cengiz M, Zorlu F, Atahan IL, Altundağ K, Güllü İ. Cancer and Radiation Therapy in Behçet’s disease.Tenth The European Cancer Conference, Vienna-Austria, September 12th-16th, 1999. The European Journal of Cancer 1999;35 (Suppl.4):S339.
107. Altundağ ÖÖ, Güllü İH, Barışta İ, Altundağ MK, Zengin N, Çelik İ, Yalçın Ş, Türker A, Güler N, Özışık Y, Kars A, Tekuzman G. Oral PECC combination chemotherapy in the treatment of the relapsed and refractory Hodgkin’s Disease and Non-Hodgkin’s lymphoma. Thirty-Sixth Annual Meeting of American Society of Clinical Oncology, New Orleans-USA, May 20th-23rd, 2000. Proceedings of American Society of Clinical Oncology 2000;19:41a, 160.
108. Güllü İ, Altundağ MK, Yalçın Ş, Altundağ Ö, Tekuzman G, Özyar E, Akyol F, Hoşal Ş, Yücel T, Kaya S. Organ preservation by induction chemotherapy plus radiotherapy in locally advanced larynx and hypopharynx cancers: Preliminary results. 25th Congress of the European Society for Medical Oncology, Hamburg -Germany, Oct 13-17th, 2000, Annals of Oncology 2000;11(Suppl 4): page 94, 421.
109. Zengin N, Kars A, Barışta İ, Güllü İH, Altundağ MK, Kansu E, Tekuzman G. The assesment of treatment results in chronic lymphocytic leukemia. 25th Congress of the European Society for Medical Oncology, Hamburg -Germany, Oct 13-17th, 2000, Annals of Oncology 2000;11(Suppl 4):page 98, 441P
110 Gökçe C, Güllü İH, Barışta İ, Zengin N, Altundağ MK, Altundağ Ö, Akçay A, Marangoz S, İzgi C. Prognostic value of serum promatrixmetalloproteinase-2 (proMMP-2) levels in colorectal cancer. 25th Congress of the European Society for Medical Oncology, Hamburg -Germany, Oct 13-17th, 2000, Annals of Oncology 2000;11(Suppl 4): page 54, 237.
111..Altundağ MK, Yalçın Ş, Baltalı E, Özışık Y, Güler N, Çelik İ, Altundağ Ö, Zengin N, Güllü İ, Tekuzman G. Results of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) combination treatment in premenopausal stage I-IIIA breast cancer patients. Second Winter European Cancer Conference WECC, Cuneo, Italy, March 8th-10th, 2001, page 7.
112.Gökçe C, Güllü İH, Barışta İ, Zengin N, Altundağ MK, Altundağ Ö, Akçay A, Marangoz S, İzgi C. Prognostic value of serum promatrixmetalloproteinase-2 (proMMP-2) levels in colorectal cancer. Second Winter European Cancer Conference WECC, Cuneo, Italy, March 8th-10th, 2001, page 20.
113.Altundağ ÖÖ, Altundağ MK, Yalçın Ş, Güllü İH, Özyar E, Akyol F, Yücel T, Hoşal Ş, Kaya S, Tekuzman G. Induction Cisplatin/5-Fluorouracil therapy followed by radiotherapy for organ preservation in locally advanced larynx cancers. Thirty-Seventh Annual Meeting of American Society of Clinical Oncology, San Francisco-USA, May 12nd-15th, 2001. Proceedings of American Society of Clinical Oncology 2001;20:205b,2572.
114.Ozturk MA, Barışta İ, Altundağ MK, Türker A, Yalçın Ş, Çelik İ, Güllü İH, Güler N, Özışık Y, Kars A, Kansu E, Baltalı E, Tekuzman. Modified ESHAP as salvage chemotherapy for recurrent or refractory Non—Hodgkin’s lymphoma: Experience at Hacettepe University and a review of the literature. Eleventh The European Cancer Conference, Lisbon-Portugal, October 21st-25th, 2001. The European Journal of Cancer 2001;37 (Suppl.6):S64, 340.
115.Altundağ K, Barışta İ, Türker A, Kars A, Güler N, Özışık Y, Güllü İ, Baltalı E, Yalçın Ş, Çelik İ, Tekuzman G. Primary Non-Hodgkin’s lymphoma of the small bowel. Forty-third Annual Meeting of American Society of Hematology, Orlando, Florida-USA, December 7th-11th, 2001, Blood 2001;98(Suppl.2):page 238b, 4677
116.Yalçın Ş, Altundağ MK, Altundağ Ö, Çelik İ, Güler N, Güllü İ, Özışık Y, Kars A, Türker A, Baltalı E, Tekuzman. Clinical evaluation of the patients with advanced stage gastric cancer in Hacettepe University. Eleventh World Congress of the International Association of Surgeons and Gastroenterologists, Heraklion, Girit, Yunanistan, December 1st-4th, 2001, Hepato-Gastroenterology, 2001, 48(Suppl.1):P-126a
117.Altundağ MK, Yalçın Ş, Altundağ Ö, Çelik İ, Güler N, Güllü İ, Özışık Y, Kars A, Türker A, Baltalı E, Tekuzman G. Clinical evaluation of the patients with operable gastric cancer in Hacettepe University. Eleventh World Congress of the International Association of Surgeons and Gastroenterologists, Heraklion, Girit, Yunanistan, December 1st-4th, 2001, Hepato-Gastroenterology, 2001, 48(Suppl.1):P-126b
118. Altundağ Ö, Güllü İ, Altundağ MK, Yalçın Ş, Cengiz M, Özyar E, Akyol F, Yücel T, Hoşal Ş, Tekuzman G. Induction Cisplatin/ 5-Fluorouracil (5-FU) therapy followed by radiotherapy for organ preservation in locally advanced larynx cancers. Thirty-Eighth Annual Meeting of American Society of Clinical Oncology, Orlando, Florida-USA,
Search: GULLU İ.
Search: GULLU İ.
Select item 240655031.
Successful treatment of benign metastasizing leiomyoma with oral alternated chemotherapeutic agents.
Sarici F, Babacan T, Altundag K, Balakan O, Gullu I.
J BUON. 2013 Jul-Sep;18(3):799. No abstract available.
PMID:
24065503
[PubMed - indexed for MEDLINE]
Related citations
Select item 233355442.
Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine.
Petekkaya I, Gezgen G, Roach EC, Solak M, Gullu I.
J BUON. 2012 Oct-Dec;17(4):796. No abstract available.
PMID:
23335544
[PubMed - indexed for MEDLINE]
Related citations
Select item 232357553.
Long-term complications in Hodgkin's lymphoma survivors.
Kilickap S, Barista I, Ulger S, Celik I, Selek U, Güllü I, Yildiz F, Kars A, Ozisik Y, Tekuzman G.
Tumori. 2012 Sep-Oct;98(5):601-6. doi: 10.1700/1190.13201.
PMID:
23235755
[PubMed - indexed for MEDLINE]
Related citations
Select item 229011984.
Ifosfamide and doxorubicin combination chemotherapy for recurrent nasopharyngeal carcinoma patients.
Dede DS, Aksoy S, Cengiz M, Gullu I, Altundag K.
Asian Pac J Cancer Prev. 2012;13(5):2225-8.
PMID:
22901198
[PubMed - indexed for MEDLINE]
Free Article
Related citations
Select item 227402155.
Tumor heparanase expression in predicting response to induction chemotherapy in patients with locally advanced laryngeal cancer.
Dincer M, Altundag K, Cengiz M, Ozyar E, Sungur A, Hosal S, Gullu IH.
J BUON. 2012 Apr-Jun;17(2):337-42.
PMID:
22740215
[PubMed - indexed for MEDLINE]
Related citations
Select item 223228366.
Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical response.
Arslan C, Aksoy S, Dizdar O, Kurt M, Güler N, Ozisik Y, Güllü I, Altundag K.
Tumori. 2011 Nov-Dec;97(6):711-6. doi: 10.1700/1018.11086.
PMID:
22322836
[PubMed - indexed for MEDLINE]
Related citations
Select item 215147377.
A retrospective comparison of robotic stereotactic body radiotherapy and three-dimensional conformal radiotherapy for the reirradiation of locally recurrent nasopharyngeal carcinoma.
Ozyigit G, Cengiz M, Yazici G, Yildiz F, Gurkaynak M, Zorlu F, Yildiz D, Hosal S, Gullu I, Akyol F.
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e263-8. doi: 10.1016/j.ijrobp.2011.02.054. Epub 2011 Apr 22.
PMID:
21514737
[PubMed - indexed for MEDLINE]
Related citations
Select item 209636418.
Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer.
Bulut N, Aksoy S, Dizdar O, Dede DS, Arslan C, Dogan E, Gullu I, Ozisik Y, Altundag K.
Med Oncol. 2011 Dec;28 Suppl 1:S75-9. doi: 10.1007/s12032-010-9715-9. Epub 2010 Oct 21.
PMID:
20963641
[PubMed - indexed for MEDLINE]
Related citations
Select item 206750759.
Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
Cengiz M, Özyiğit G, Yazici G, Doğan A, Yildiz F, Zorlu F, Gürkaynak M, Gullu IH, Hosal S, Akyol F.
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):104-9. doi: 10.1016/j.ijrobp.2010.04.027. Epub 2010 Aug 2.
PMID:
20675075
[PubMed - indexed for MEDLINE]
Related citations
Select item 2041475110.
FDG-PET/CT in the evaluation of epithelioid hemangioendothelioma of the liver: the role of dual-time-point imaging. A case presentation and review of the literature.
Kitapci MT, Akkaş BE, Gullu I, Sokmensuer C.
Ann Nucl Med. 2010 Aug;24(7):549-53. doi: 10.1007/s12149-010-0379-5. Epub 2010 Apr 23.
PMID:
20414751
[PubMed - indexed for MEDLINE]
Related citations
Select item 2021725511.
How shall we name the chemotherapy administration before and after metastasectomy? How about "M-neoadjuvant" and "M-adjuvant"?
Abali H, Dişel U, Urün Y, Güllü I, Saif MW.
Ann Surg Oncol. 2010 Jul;17(7):1970. doi: 10.1245/s10434-010-1011-6. Epub 2010 Mar 9. No abstract available.
PMID:
20217255
[PubMed - indexed for MEDLINE]
Related citations
Select item 2011624212.
Clinical and pathological characteristics of breast cancer patients with history of tonsillectomy.
Isik M, Aksoy S, Dede DS, Dizdar O, Kara A, Gullu I, Ozisik Y, Altundag K.
Breast. 2010 Apr;19(2):152. doi: 10.1016/j.breast.2009.12.008. Epub 2010 Jan 29. No abstract available.
PMID:
20116242
[PubMed - indexed for MEDLINE]
Related citations
Select item 2009904913.
Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer.
Sari E, Guler G, Hayran M, Gullu I, Altundag K, Ozisik Y.
Med Oncol. 2011 Mar;28(1):57-63. doi: 10.1007/s12032-010-9418-2. Epub 2010 Jan 23.
PMID:
20099049
[PubMed - indexed for MEDLINE]
Related citations
Select item 1988574714.
Blood ABO groups and risk of breast cancer.
Dede DS, Aksoy S, Dizdar O, Cerci P, Gullu I, Ozisik Y, Altundag K.
Med Oncol. 2010 Dec;27(4):1433. doi: 10.1007/s12032-009-9346-1. No abstract available.
PMID:
19885747
[PubMed - indexed for MEDLINE]
Related citations
Select item 1850720415.
Characteristics of breast cancer patients with central nervous system metastases: a single-center experience.
Harputluoglu H, Dizdar O, Aksoy S, Kilickap S, Dede DS, Ozisik Y, Guler N, Barista I, Gullu I, Hayran M, Selek U, Cengiz M, Zorlu F, Tekuzman G, Altundag K.
J Natl Med Assoc. 2008 May;100(5):521-6.
PMID:
18507204
[PubMed - indexed for MEDLINE]
Related citations
Select item 1819648016.
Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases.
Dincer M, Altundag K, Harputluoglu H, Aksoy S, Cengiz M, Gullu I.
Med Oncol. 2008;25(3):356-9. doi: 10.1007/s12032-008-9045-3. Epub 2008 Jan 15.
PMID:
18196480
[PubMed - indexed for MEDLINE]
Related citations
Select item 1791355017.
Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management.
Altundag K, Dede D, Harputluoglu H, Gullu I.
Joint Bone Spine. 2007 Dec;74(6):662-3. Epub 2007 Aug 13. No abstract available.
PMID:
17913550
[PubMed - indexed for MEDLINE]
Related citations
Select item 1784875018.
Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer.
Cengiz M, Zorlu F, Yalcin S, Gurkaynak M, Atahan IL, Gullu IH.
Med Oncol. 2007;24(2):239-43.
PMID:
17848750
[PubMed - indexed for MEDLINE]
Related citations
Select item 1766120619.
Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
Turen S, Ozyar E, Altundag K, Gullu I, Atahan IL.
Cancer Invest. 2007 Aug;25(5):315-21.
PMID:
17661206
[PubMed - indexed for MEDLINE]
Related citations
Select item 1740102620.
Potential chemotherapy options in the triple negative subtype of breast cancer.
Altundag K, Harputluoglu H, Aksoy S, Gullu IH.
J Clin Oncol. 2007 Apr 1;25(10):1294-5; author reply 1295-6. No abstract available.
PMID:
17401026
[PubMed - indexed for MEDLINE]
Related citations
Select item 1731404721.
Potential molecular targeted therapies in the management of the basal-like subtype of breast cancer.
Kurt M, Harputluoglu H, Dede DS, Gullu IH, Altundag K.
Breast. 2007 Apr;16(2):111-2. Epub 2007 Feb 20. No abstract available.
PMID:
17314047
[PubMed - indexed for MEDLINE]
Related citations
Select item 1706502022.
Mucosa associated lymphoid tissue lymphoma of the sub-mandibular gland presenting with relapse in the lacrimal gland.
Kurt M, Shorbagi A, Altundag K, Yilmaz YA, Dizdar O, Gullu I.
Leuk Lymphoma. 2006 Sep;47(9):1982-4. No abstract available.
PMID:
17065020
[PubMed - indexed for MEDLINE]
Related citations
Select item 1664524123.
Peripheral T-cell lymphoma and Job's syndrome: a rare association.
Onal IK, Kurt M, Altundag K, Aksoy S, Dincer M, Gullu I.
Med Oncol. 2006;23(1):141-4.
PMID:
16645241
[PubMed - indexed for MEDLINE]
Related citations
Select item 1660814024.
Complications due to late diagnosis of celiac disease with co-existing plasma cell dyscrasia in an elderly patient.
Cankurtaran M, Ulger Z, Doğan S, Balam Yavuz B, Halil M, Güllü I, Gedikoğlu G, Anioğul S.
Aging Clin Exp Res. 2006 Feb;18(1):75-7.
PMID:
16608140
[PubMed - indexed for MEDLINE]
Related citations
Select item 1624775525.
Possible association between Budd-Chiari Syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia.
Kurt M, Shorbagi A, Altundag K, Elkiran T, Güllü I, Kansu E.
Am J Hematol. 2005 Nov;80(3):213-5.
PMID:
16247755
[PubMed - indexed for MEDLINE]
Related citations
Select item 1596528526.
Acute tumor lysis syndrome triggered by zoledronic Acid in a patient with metastatic lung adenocarcinoma.
Kurt M, Onal IK, Elkiran T, Altun B, Altundag K, Gullu I.
Med Oncol. 2005;22(2):203-6.
PMID:
15965285
[PubMed - indexed for MEDLINE]
Related citations
Select item 1551515827.
Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
Altundag O, Gullu I, Altundag K, Yalcin S, Ozyar E, Cengiz M, Akyol F, Yucel T, Hosal S, Sozeri B.
Head Neck. 2005 Jan;27(1):15-21.
PMID:
15515158
[PubMed - indexed for MEDLINE]
Related citations
Select item 1550456828.
Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis.
Altundag O, Altundag K, Selim Silay Y, Gunduz M, Demircan K, Gullu I.
Med Hypotheses. 2004;63(6):1010-3.
PMID:
15504568
[PubMed - indexed for MEDLINE]
Related citations
Select item 1546520129.
Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
Yildiz F, Zengin N, Engin H, Güllü I, Barista I, Caglar M, Ozyar E, Cengiz M, Gürkaynak M, Zorlu F, Caner B, Atahan IL, Tekuzman G.
Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):839-46.
PMID:
15465201
[PubMed - indexed for MEDLINE]
Related citations
Select item 1545694730.
Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy.
Altundag K, Aksoy S, Gullu I, Altundag O, Ozyar E, Yalcin S, Cengiz M, Akyol F.
Med Oncol. 2004;21(3):211-5.
PMID:
15456947
[PubMed - indexed for MEDLINE]
Related citations
Select item 1514265331.
Hypocalcemic effect of zoledronic acid or other bisphosphonates may contribute to their antiangiogenic properties.
Aksoy S, Abali H, Dinçer M, Kilickap S, Güllü I, Tekuzman G.
Med Hypotheses. 2004;62(6):942-4.
PMID:
15142653
[PubMed - indexed for MEDLINE]
Related citations
Select item 1471198332.
Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer.
Yalcin S, Oksuzoglu B, Tekuzman G, Engin H, Celik I, Turker A, Barista I, Gullu I, Guler N, Altundag K, Ozisik Y, Kars A.
Jpn J Clin Oncol. 2003 Nov;33(11):580-3.
PMID:
14711983
[PubMed - indexed for MEDLINE]
Free Article
Related citations
Select item 1284166033.
Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: efficacy and prognostic factors.
Karaoğlu A, Yalcin S, Tekuzman G, Kars A, Celik I, Güler N, Ozişik Y, Türker A, Barişta I, Güllü I.
Tumori. 2003 Mar-Apr;89(2):141-5.
PMID:
12841660
[PubMed - indexed for MEDLINE]
Related citations
Select item 1247604234.
Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin.
Oztürk MA, Barişta I, Altundağ MK, Türker A, Yalçin S, Celik I, Güllü I, Güler N, Ozişik Y, Kars A, Kansu E, Baltali E, Tekuzman G.
Chemotherapy. 2002 Dec;48(5):252-8.
PMID:
12476042
[PubMed - indexed for MEDLINE]
Related citations
Select item 1246144935.
Effects of growth factors on doxorubicin-induced skin necrosis: documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF.
Vargel I, Erdem A, Ertoy D, Pinar A, Erk Y, Altundag MK, Gullu I.
Ann Plast Surg. 2002 Dec;49(6):646-53.
PMID:
12461449
[PubMed - indexed for MEDLINE]
Related citations
Select item 1220816736.
Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Abali H, Güllü IH, Engin H, Haznedaroğlu IC, Erman M, Tekuzman G.
Med Hypotheses. 2002 Sep;59(3):344-8.
PMID:
12208167
[PubMed - indexed for MEDLINE]
Related citations
Select item 1215198037.
Relapsed prolactinoma 27 years after conventional radiotherapy.
Köklü S, Onat AM, Erol K, Kiliçarslan A, Altundag MK, Güllü I.
Am J Clin Oncol. 2002 Aug;25(4):429-30. No abstract available.
PMID:
12151980
[PubMed - indexed for MEDLINE]
Related citations
Select item 1201737938.
A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer.
Basaran M, Bavbek SE, Güllü I, Demirelli F, Sakar B, Tenekeci N, Altun M, Yalçin S, Onat H.
J Chemother. 2002 Apr;14(2):207-13.
PMID:
12017379
[PubMed - indexed for MEDLINE]
Related citations
Select item 1169942039.
Myasthenia gravis and lymphoblastic lymphoma involving the thymus: a rare association.
Uner AH, Abali H, Engin H, Akyol A, Ruacan S, Tan E, Güllü I, Altundağ K, Güler N.
Leuk Lymphoma. 2001 Jul;42(3):527-31.
PMID:
11699420
[PubMed - indexed for MEDLINE]
Related citations
Select item 1152962840.
Malignancy in Behçet's disease: a report of 13 cases and a review of the literature.
Cengiz M, Altundag MK, Zorlu AF, Güllü IH, Ozyar E, Atahan IL.
Clin Rheumatol. 2001;20(4):239-44. Review.
PMID:
11529628
[PubMed - indexed for MEDLINE]
Related citations
Select item 1146118041.
Is there a relationship between tissue inhibitor of metalloproteinase-1 and transforming growth factor-beta 1 with respect to malignant melanoma progression?
Kurdoglu M, Güllü IH, Akalin I.
Med Hypotheses. 2001 Aug;57(2):238-40.
PMID:
11461180
[PubMed - indexed for MEDLINE]
Related citations
Select item 1146117742.
Why hepatocellular carcinoma cells are unlikely to metastasize: is there a role for tissue inhibitor of metalloproteinase-1?
Akalin I, Güllü IH, Kurdoglu M, Marangoz S.
Med Hypotheses. 2001 Aug;57(2):221-3.
PMID:
11461177
[PubMed - indexed for MEDLINE]
Related citations
Select item 1085900143.
Primary breast lymphomas--a retrospective analysis of twelve cases.
Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D.
Acta Oncol. 2000;39(2):135-9.
PMID:
10859001
[PubMed - indexed for MEDLINE]
Related citations
Select item 1084132144.
Serum L-selectin and P-selectin levels in lymphomas.
Haznedaroglu IC, Benekli M, Ozcebe O, Savaş MC, Güllü IH, Dündar SV, Kirazli S.
Haematologia (Budap). 2000;30(1):27-30.
PMID:
10841321
[PubMed - indexed for MEDLINE]
Related citations
Select item 1064927245.
Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy.
Barişta I, Tekuzman G, Yalçin S, Güllü I, Güler N, Ozişik Y, Kars A, Celik I, Türker A, Altundağ K, Zengin N, Uner A, Baltali E, Firat D.
J Surg Oncol. 2000 Jan;73(1):12-6.
PMID:
10649272
[PubMed - indexed for MEDLINE]
Related citations
Select item 1063899946.
The relation of gelatinase (MMP-2 and -9) expression with distant site metastasis and tumour aggressiveness in colorectal cancer.
Güllü IH, Kurdoğlu M, Akalin I.
Br J Cancer. 2000 Jan;82(1):249. No abstract available.
PMID:
10638999
[PubMed - indexed for MEDLINE]
Free PMC Article
Related citations
Select item 1048763447.
Effect of acetic acid on telomerase activity in premalignant and malignant cervical lesions.
Güllü IH, Kurdoğlu M.
Br J Cancer. 1999 Sep;81(1):186. No abstract available.
PMID:
10487634
[PubMed - indexed for MEDLINE]
Free PMC Article
Related citations
Select item 1046831148.
Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer.
Güllü IH, Marangoz S.
Br J Cancer. 1999 Aug;80(11):1865. No abstract available.
PMID:
10468311
[PubMed - indexed for MEDLINE]
Related citations
Select item 1037511749.
Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia.
Marangoz S, Güllü IH.
Cancer. 1999 Jun 15;85(12):2668-9. No abstract available.
PMID:
10375117
[PubMed - indexed for MEDLINE]
Related citations
Select item 1035489050.
US and CT findings of multicentric leiomyosarcomatosis.
Akata D, Aralasmak A, Ozmen MN, Akhan O, Altundağ K, Güllü I.
Eur Radiol. 1999;9(4):711-4.
PMID:
10354890
[PubMed - indexed for MEDLINE]
Related citations
Select item 1018891651.
Induction of cachexia in mice.
Güllü I, Marangoz S.
Br J Cancer. 1999 Mar;79(9-10):1620-1. No abstract available.
PMID:
10188916
[PubMed - indexed for MEDLINE]
Free PMC Article
Related citations
Select item 1007673552.
Telomerase or telomersyn?
Güllü IH, Marangoz S.
Ann Oncol. 1999 Jan;10(1):125. No abstract available.
PMID:
10076735
[PubMed - indexed for MEDLINE]
Free Article
Related citations
Select item 982063353.
VB-CHEP chemotherapy regimen for aggressive non-Hodgkin's lymphomas.
Yalçin S, Kars A, Ozişik Y, Tekuzman G, Ozyilkan O, Celik I, Barişta I, Güllü I, Güler N, Baltali E, Firat D.
Eur J Haematol. 1998 Oct;61(4):261-5.
PMID:
9820633
[PubMed - indexed for MEDLINE]
Related citations
Select item 980666654.
Plasma thrombospondin levels in patients with colorectal carcinoma.
Gullu IH, Marangoz S.
Cancer. 1998 Nov 1;83(9):2043-5. No abstract available.
PMID:
9806666
[PubMed - indexed for MEDLINE]
Related citations
Select item 968330555.
Circulating intercellular adhesion molecule-1 and E-selectin levels in gastric cancer.
Benekli M, Güllü IH, Tekuzman G, Savaş MC, Hayran M, Hasçelik G, Firat D.
Br J Cancer. 1998 Jul;78(2):267-71.
PMID:
9683305
[PubMed - indexed for MEDLINE]
Free PMC Article
Related citations
Select item 967953656.
Comparison of CEA and CA 125 levels in the ascites and serum of patients with ovarian carcinoma.
Yalçin S, Güllü I.
Cancer Invest. 1998;16(6):426-7. No abstract available.
PMID:
9679536
[PubMed - indexed for MEDLINE]
Related citations
Select item 967952557.
Bolus and continuous infusion mitoxantrone in newly diagnosed adult acute lymphoblastic leukemia: results of two consecutive phase II clinical studies.
Koc Y, Akpek G, Kansu E, Kars A, Tekuzman G, Baltali E, Güler N, Barista I, Güllü I, Ozisik Y, Firat D.
Cancer Invest. 1998;16(6):355-65. Review.
PMID:
9679525
[PubMed - indexed for MEDLINE]
Related citations
Select item 962767558.
Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy.
Yalçin S, Güllü I, Barişta I, Tekuzman G, Ozişik Y, Celik I, Kars A.
Cancer Invest. 1998;16(5):297-302.
PMID:
9627675
[PubMed - indexed for MEDLINE]
Related citations
Select item 961627859.
nm23 Protein expression in larynx cancer and the relationship with metastasis.
Gunduz M, Ayhan A, Gullu I, Onerci M, Hosal AS, Gursel B, Hosal IN, Firat D.
Eur J Cancer. 1997 Dec;33(14):2338-41.
PMID:
9616278
[PubMed - indexed for MEDLINE]
Related citations
Select item 960947560.
Persistent hypercalcemia leading to acute pancreatitis in a patient with relapsed myeloma and renal failure.
Celik I, Apraş S, Kars A, Barişta I, Güllü I, Güler N, Kansu E.
Nephron. 1998;79(1):109-10. No abstract available.
PMID:
9609475
[PubMed - indexed for MEDLINE]
Related citations
Select item 960947461.
Renal cell carcinoma presenting as solitary cervical node metastasis compressing the brachial plexus.
Savaş MC, Celik I, Benekli M, Güllü IH, Tekuzman G.
Nephron. 1998;79(1):107-8. No abstract available.
PMID:
9609474
[PubMed - indexed for MEDLINE]
Related citations
Select item 959286762.
Ischemic heart disease in Behçet's syndrome.
Benekli M, Güllü IH, Haznedaroğlu IC.
Rheumatol Int. 1998;17(6):251. No abstract available.
PMID:
9592867
[PubMed - indexed for MEDLINE]
Related citations
Select item 953720963.
A comparison of two nonsteroidal antiinflammatory drugs (diflunisal versus dipyrone) in the treatment of moderate to severe cancer pain: a randomized crossover study.
Yalçin S, Güllü IH, Tekuzman G, Savaş C, Firat D.
Am J Clin Oncol. 1998 Apr;21(2):185-8.
PMID:
9537209
[PubMed - indexed for MEDLINE]
Related citations
Select item 945169564.
Small intestinal perforation in Hodgkin's disease.
Benekli M, Akpek G, Güllü IH, Ruacan S, Barişta I, Ayhan A, Tekuzman G, Firat D.
J Clin Gastroenterol. 1997 Dec;25(4):699-701. No abstract available.
PMID:
9451695
[PubMed - indexed for MEDLINE]
Related citations
Select item 937360065.
Hippocratic fingers in Behçet's disease.
Benekli M, Güllü IH.
Postgrad Med J. 1997 Sep;73(863):575-6.
PMID:
9373600
[PubMed - indexed for MEDLINE]
Free PMC Article
Related citations
Select item 932826866.
Primary central nervous system lymphoma presenting with multiple myeloma-like clinical picture.
Celik I, Basçil N, Barista I, Güllü I, Tekuzman G, Firat D.
J Neurol Neurosurg Psychiatry. 1997 Sep;63(3):409-10. No abstract available.
PMID:
9328268
[PubMed - indexed for MEDLINE]
Free PMC Article
Related citations
Select item 934249667.
Lupus nephritis in a patient with idiopathic thrombocytopenic purpura diagnosed 11 years earlier.
Yalçin S, Demiroğlu H, Güllü I, Barişta I.
Clin Nephrol. 1997 Sep;48(3):201-2. No abstract available.
PMID:
9342496
[PubMed - indexed for MEDLINE]
Related citations
Select item 933735468.
Proposed modification of the "real Working" classification of lymphoid neoplasms.
Haznedaroglu IC, Büyükaşik Y, Benekli M, Güllü IH.
J Natl Cancer Inst. 1997 Oct 15;89(20):1546. No abstract available.
PMID:
9337354
[PubMed - indexed for MEDLINE]
Related citations
Select item 929385769.
Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma.
Kars A, Celik I, Kansu E, Tekuzman G, Ozişik Y, Güler N, Barişta I, Güllü I, Yalçin S, Altundağ K, Zengin N, Türker A, Hayran M, Baltali E, Firat D.
Eur J Haematol. 1997 Aug;59(2):100-4.
PMID:
9293857
[PubMed - indexed for MEDLINE]
Related citations
Select item 926440170.
Intrathecal chemotherapy and bone marrow.
Barişta I, Celik I, Güllü IH, Yalçin S.
Leukemia. 1997 Aug;11(8):1392-3. No abstract available.
PMID:
9264401
[PubMed - indexed for MEDLINE]
Related citations
Select item 918472771.
Clarithromycin-induced fever in a patient with Helicobacter pylori gastritis.
Kadayifçi A, Gullu IH, Aka H.
Ann Pharmacother. 1997 Jun;31(6):788. No abstract available.
PMID:
9184727
[PubMed - indexed for MEDLINE]
Related citations
Select item 914518972.
The significance and distinct interactions of various growth factors in physiologic and pathologic megakaryocytopoiesis/thrombocytopoiesis.
Haznedaroglu IC, Gullu IH, Dundar S, Kirazli S.
Aust N Z J Med. 1997 Apr;27(2):191-2. No abstract available.
PMID:
9145189
[PubMed - indexed for MEDLINE]
Related citations
Select item 914219373.
Multiple lymphomatous polyposis.
Kadayifçi A, Benekli M, Savaş MC, Arslan S, Uzunalimoğlu B, Barişta I, Güllü IH, Tekuzman G.
J Surg Oncol. 1997 Apr;64(4):336-40.
PMID:
9142193
[PubMed - indexed for MEDLINE]
Related citations
Select item 923261474.
Acute leukaemia during tamoxifen therapy.
Yalçin S, Güllü I, Demiroğlu H, Tekuzman G.
Med Oncol. 1997 Mar;14(1):61-2.
PMID:
9232614
[PubMed - indexed for MEDLINE]
Related citations
Select item 922602975.
Ifosfamide and etoposide in previously treated patients with advanced breast cancer.
Kiraz S, Baltali E, Güler N, Barişta I, Benekli M, Celik I, Güllü IH, Kars A, Tekuzman G, Firat D.
Tumori. 1997 Mar-Apr;83(2):604-7.
PMID:
9226029
[PubMed - indexed for MEDLINE]
Related citations
Select item 907773676.
Ursodeoxycholic acid in the management of prolonged cholestasis of acute hepatitis B.
Kadayifci A, Savas MC, Arslan S, Güllú IH.
J Clin Gastroenterol. 1997 Mar;24(2):125-6. No abstract available.
PMID:
9077736
[PubMed - indexed for MEDLINE]
Related citations
Select item 906695577.
Disulfiram-ethanol test reaction: significance of supervision.
Savas MC, Güllü IH.
Ann Pharmacother. 1997 Mar;31(3):374-5. No abstract available.
PMID:
9066955
[PubMed - indexed for MEDLINE]
Related citations
Select item 938022678.
Hematological side effects of ACE inhibitors and a hypothetical local renin-angiotensin system in the bone marrow.
Haznedaroğlu IC, Güllü IH.
Nephron. 1997;77(1):111. No abstract available.
PMID:
9380226
[PubMed - indexed for MEDLINE]
Related citations
Select item 920891179.
Ifosfamide-based chemotherapy for recurrent or metastatic hemangiopericytoma.
Celik I, Başçil N, Yalçin S, Güllü IH, Kars A, Barişta I, Tekuzman G.
Acta Oncol. 1997;36(3):348. No abstract available.
PMID:
9208911
[PubMed - indexed for MEDLINE]
Related citations
Select item 914044680.
Ketorolac tromethamine in cancer pain.
Yalçin S, Güllü I, Tekuzman G, Savaş C.
Acta Oncol. 1997;36(2):231-2. No abstract available.
PMID:
9140446
[PubMed - indexed for MEDLINE]
Related citations
Select item 893167381.
Factors influencing the distribution of metastases and survival in metastatic breast carcinoma.
Barişta I, Baltali E, Güllü IH, Güler N, Celik I, Saraçbaşi O, Tekuzman G, Kars A, Ozişik Y, Ruacan S, Atahan IL, Firat D.
Am J Clin Oncol. 1996 Dec;19(6):569-73.
PMID:
8931673
[PubMed - indexed for MEDLINE]
Related citations
Select item 889088782.
The significance of megakaryocytopoietic cytokines and thrombopoietin in immune thrombocytopenic purpura: a hypothesis.
Haznedaroğlu IC, Savas CM, Benkli M, Gullu IH, Dundar SV.
N Z Med J. 1996 Oct 11;109(1031):389. No abstract available.
PMID:
8890887
[PubMed - indexed for MEDLINE]
Related citations
Select item 1742926383.
Difficult diagnosis in a patient with multiple osteoblastic thoracic vertebral lesions.
Celik I, Bascil N, Güllü I, Barista I, Camurdanoglu M.
Ann Saudi Med. 1996 Sep;16(5):590. No abstract available.
PMID:
17429263
[PubMed]
Related citations
Select item 877461384.
Nurses annoyed by pinching and nudging.
Savas MC, Güllü IH.
Lancet. 1996 Aug 31;348(9027):626. No abstract available.
PMID:
8774613
[PubMed - indexed for MEDLINE]
Related citations
Select item 887383985.
Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer.
Kiraz S, Baltali E, Güler N, Barista I, Benekli M, Celik I, Güllü IH, Kars A, Tekuzman G, Firat D.
J Chemother. 1996 Aug;8(4):310-4.
PMID:
8873839
[PubMed - indexed for MEDLINE]
Related citations
Select item 887383486.
Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections.
Akova M, Ozcebe O, Güllü I, Unal S, Gür D, Akalin S, Tokgözoglu M, Telatar F, Akalin HE.
J Chemother. 1996 Aug;8(4):284-9.
PMID:
8873834
[PubMed - indexed for MEDLINE]
Related citations
Select item 881908887.
Acute tumor lysis syndrome following intrathecal methotrexate.
Benekli M, Güllü IH, Savaş MC, Kadayifçi A, Altundağ MK, Tekuzman G, Firat D.
Leuk Lymphoma. 1996 Jul;22(3-4):361-3.
PMID:
8819088
[PubMed - indexed for MEDLINE]
Related citations
Select item 861831588.
Dramatic response to ifosfamide, mesna and doxorubicin chemotherapy regimen in an adult with clear cell sarcoma of the kidney.
Yalçin S, Barişta I, Tekuzman G, Güllü I, Firat D.
J Urol. 1996 Jun;155(6):2024. No abstract available.
PMID:
8618315
[PubMed - indexed for MEDLINE]
Related citations
Select item 869359989.
Procarbazine, CCNU, vincristine combination in the treatment of brain tumors.
Güllü IH, Celik I, Tekuzman G, Altunbaş M, Güler N, Barişta I, Alkiş N, Yalçin S, Kars A, Baltali E, Kansu E, Firat D.
Tumori. 1996 May-Jun;82(3):228-31.
PMID:
8693599
[PubMed - indexed for MEDLINE]
Related citations
Select item 888204090.
Silent myocardial ischemia in Behçet's disease.
Güllü IH, Benekli M, Müderrisoğlu H, Oto A, Kansu E, Kabakçi G, Oram E, Bekdik C.
J Rheumatol. 1996 Feb;23(2):323-7.
PMID:
8882040
[PubMed - indexed for MEDLINE]
Related citations
Select item 884772691.
Integrating the time factor into the definition of metastasis of unknown origin.
Barista I, Celik I, Güllü I, Hayran M, Akova M.
J Natl Cancer Inst. 1996 Jan 3;88(1):51. No abstract available.
PMID:
8847726
[PubMed - indexed for MEDLINE]
Free Article
Related citations
Select item 873861392.
Phaeochromocytoma in pregnancy: a case report.
Atan A, Yildiz M, Aydoganli L, Gullu I, Akalin Z.
Int Urol Nephrol. 1996;28(1):11-3.
PMID:
8738613
[PubMed - indexed for MEDLINE]
Related citations
Select item 863068693.
High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomas.
Güllü I, Yalçin S, Tekuzman G, Barişta I, Alkiş N, Celik I, Zengin N, Güler N, Kars A, Baltali E, et al.
Cancer Invest. 1996;14(3):239-42.
PMID:
8630686
[PubMed - indexed for MEDLINE]
Related citations
Select item 852943894.
Tumor lysis syndrome following single-dose mitoxantrone.
Benekli M, Savaş MC, Güllü IH, Kadayifçi A, Akpek G, Kars A, Güler N, Kansu E, Tekuzman G, Firat D.
Chemotherapy. 1995 Nov-Dec;41(6):470-2.
PMID:
8529438
[PubMed - indexed for MEDLINE]
Related citations
Select item 854011795.
Non-Hodgkin's lymphomas of the tonsil: a retrospective analysis of twenty-eight patients with primary tonsillary lymphoma.
Barişta I, Tekuzman G, Güllü I, Baltali E, Kars A, Ozişik Y, Güler N, Celik I, Atahan IL, Firat D.
Tumori. 1995 Jul-Aug;81(4):234-7.
PMID:
8540117
[PubMed - indexed for MEDLINE]
Related citations
Select item 134147796.
Familial Behçet's disease.
Akpolat T, Koç Y, Yeniay I, Akpek G, Güllü I, Kansu E, Kiraz S, Ersoy F, Batman F, Kansu T, et al.
Eur J Med. 1992 Nov;1(7):391-5. Review.
PMID:
1341477
[PubMed - indexed for MEDLINE]
Related citations
Select item 157845497.
Vascular involvement in Behçet's disease.
Koç Y, Güllü I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkanci F, Akkaya S, et al.
J Rheumatol. 1992 Mar;19(3):402-10.
PMID:
1578454
Create File
Search: GULLU İ.
GULLU I. (97)
Kanserde Yeni Tedavi Yaklaşımları Angiogenesis ve angiogenez inhibitörleri, Metastaz Biyolojisi Antimetastatik Tedaviler Kanserde Alternatif Tedaviler
Lise |
|
||||||||||||
Lisans |
|
||||||||||||
Yüksek Öğrenim |
|
||||||||||||
Yabancı Dil | İngilizce |
:
: ibrahimhalil.gullu@hacettepe.edu.tr